Boehringer Ingelheim Gmbh (Germany)
Industry and Market Reports

 

List of associated reports

Below is a list of reports where Boehringer Ingelheim Gmbh (Germany) is mentioned. The list of reports for the company is categorised by Industry, Region and report type. This categorisation along with the number of reports in each category is shown in the region on the left.

Many of the reports mention companies other than Boehringer Ingelheim Gmbh (Germany) in the same report. This provides an indication of potential competitors or associated to Boehringer Ingelheim Gmbh (Germany). The relevance ranking is a measure of how many times both companies are mentioned in the same reported. These associated companies can me clicked to find out more about the company.

View Report: Research and Experts Market Report: Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1) - Pipeline Review, H2 2016

Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1) - Pipeline Review, H2 2016


2016-11-30
Global Markets Direct’s, ‘Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1) - Pipeline Review, H2 2016’, provides in depth analysis on Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1)...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0700TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0700TDB
  • View Report: Research and Experts Market Report: Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY ESO 1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2...

    Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY ESO 1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A or CTAG1B) - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct’s, ‘Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY ESO 1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A or CTAG1B) - Pipeline Review, H2 2016’, provides in depth analysis on...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0698TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0698TDB
  • View Report: Research and Experts Market Report: Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2016

    Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2016


    2016-12-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Glioblastoma Multiforme (GBM) – Pipeline Review, H2 2016, provides an overview of the Glioblastoma Multiforme (GBM) (Oncology) pipeline landscape.

    Glioblastoma...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8858IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8858IDB
  • View Report: Research and Experts Market Report: Liver Cancer - Pipeline Review, H2 2016

    Liver Cancer - Pipeline Review, H2 2016


    2016-12-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Liver Cancer – Pipeline Review, H2 2016, provides an overview of the Liver Cancer (Oncology) pipeline landscape.

    Liver cancer starts in the liver. The risk...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8854IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8854IDB
  • View Report: Research and Experts Market Report: Colon Cancer - Pipeline Review, H2 2016

    Colon Cancer - Pipeline Review, H2 2016


    2016-12-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Colon Cancer – Pipeline Review, H2 2016, provides an overview of the Colon Cancer (Oncology) pipeline landscape.

    Colon cancer is cancer that starts in the large...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8848IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8848IDB
  • View Report: Research and Experts Market Report: Colorectal Cancer - Pipeline Review, H2 2016

    Colorectal Cancer - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Colorectal Cancer – Pipeline Review, H2 2016, provides an overview of the Colorectal Cancer (Oncology) pipeline landscape.

    Colon cancer is cancer that starts...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8870IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8870IDB
  • View Report: Research and Experts Market Report: Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2016

    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Myelocytic Leukemia – Pipeline Review, H2 2016, provides an overview of the Acute Myelocytic Leukemia (Oncology) pipeline landscape.

    Acute myelocytic...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8869IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8869IDB
  • View Report: Research and Experts Market Report: Melanoma - Pipeline Review, H2 2016

    Melanoma - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Melanoma – Pipeline Review, H2 2016, provides an overview of the Melanoma (Oncology) pipeline landscape.

    Melanoma is a tumor that develops as a result of the...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8868IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8868IDB
  • View Report: Research and Experts Market Report: Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H2 2016

    Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Human Immunodeficiency Virus Infections (AIDS) – Pipeline Review, H2 2016, provides an overview of the Human Immunodeficiency Virus Infections (AIDS) (Infectious...
  • Market Report
  • Infectious Disease
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8867IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8867IDB
  • View Report: Research and Experts Market Report: Ovarian Cancer - Pipeline Review, H2 2016

    Ovarian Cancer - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ovarian Cancer – Pipeline Review, H2 2016, provides an overview of the Ovarian Cancer (Oncology) pipeline landscape.

    Ovarian cancer is any cancerous growth...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8866IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8866IDB
  • View Report: Research and Experts Market Report: Rheumatoid Arthritis - Pipeline Review, H2 2016

    Rheumatoid Arthritis - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rheumatoid Arthritis – Pipeline Review, H2 2016, provides an overview of the Rheumatoid Arthritis (Immunology) pipeline landscape.

    Rheumatoid arthritis (RA)...

  • Market Report
  • Immunology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8865IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8865IDB
  • View Report: Research and Experts Market Report: Non-Small Cell Lung Cancer - Pipeline Review, H2 2016

    Non-Small Cell Lung Cancer - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Non-Small Cell Lung Cancer – Pipeline Review, H2 2016, provides an overview of the Non-Small Cell Lung Cancer (Oncology) pipeline landscape.

    Non-small cell...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8864IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8864IDB
  • View Report: Research and Experts Market Report: Pancreatic Cancer - Pipeline Review, H2 2016

    Pancreatic Cancer - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pancreatic Cancer – Pipeline Review, H2 2016, provides an overview of the Pancreatic Cancer (Oncology) pipeline landscape.

    Pancreatic cancer is a disease in...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8862IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8862IDB
  • View Report: Research and Experts Market Report: Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) - Pipeline Review, H2 2016

    Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) - Pipeline Review, H2 2016


    2016-11-23
    Global Markets Direct’s, ‘Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) - Pipeline Review, H2 2016’, provides in depth analysis on Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) targeted pipeline therapeutics.

    The report provides comprehensive...

  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0678TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0678TDB
  • View Report: Research and Experts Market Report: Prostate Cancer - Pipeline Review, H2 2016

    Prostate Cancer - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Prostate Cancer – Pipeline Review, H2 2016, provides an overview of the Prostate Cancer (Oncology) pipeline landscape.

    Prostate cancer is a form of cancer that...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8860IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8860IDB
  • View Report: Research and Experts Market Report: Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H2 2016

    Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Kidney Cancer (Renal Cell Cancer) – Pipeline Review, H2 2016, provides an overview of the Kidney Cancer (Renal Cell Cancer) (Oncology) pipeline landscape.

    Kidney...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8816IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8816IDB
  • View Report: Research and Experts Market Report: Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) - Pipeline Review, H2 2016

    Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct’s, ‘Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) - Pipeline Review, H2 2016’, provides in depth analysis on Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) targeted pipeline...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0672TDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC0672TDB
  • View Report: Research and Experts Market Report: Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) - Pipeline...

    Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct’s, ‘Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) - Pipeline Review, H2 2016’, provides in depth analysis on Fibroblast Growth Factor Receptor...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0670TDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC0670TDB
  • View Report: Research and Experts Market Report: Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) - Pipeline...

    Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct’s, ‘Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) - Pipeline Review, H2 2016’, provides in depth analysis on Fibroblast Growth Factor Receptor...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0669TDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC0669TDB
  • View Report: Research and Experts Market Report: Mucin 1 (Breast Carcinoma Associated Antigen DF3 or Episialin or H23AG or Krebs Von Den Lungen 6 or PEMT or Peanut Reactive Urinary...

    Mucin 1 (Breast Carcinoma Associated Antigen DF3 or Episialin or H23AG or Krebs Von Den Lungen 6 or PEMT or Peanut Reactive Urinary Mucin or Polymorphic Epithelial Mucin or Tumor Associated Epithelial Membrane Antigen or Tumor Associated Mucin or CD227 or


    2016-11-16
    Global Markets Direct’s, ‘Mucin 1 (Breast Carcinoma Associated Antigen DF3 or Episialin or H23AG or Krebs Von Den Lungen 6 or PEMT or Peanut Reactive Urinary Mucin or Polymorphic Epithelial Mucin or Tumor Associated Epithelial Membrane Antigen...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0658TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0658TDB
  • View Report: Research and Experts Market Report: Fibroblast Growth Factor Receptor 1 (Basic Fibroblast Growth Factor Receptor 1 or Fms Like Tyrosine Kinase 2 or N Sam or Proto Oncogene...

    Fibroblast Growth Factor Receptor 1 (Basic Fibroblast Growth Factor Receptor 1 or Fms Like Tyrosine Kinase 2 or N Sam or Proto Oncogene c Fgr or CD331 or FLT2 or FGFR1 or EC 2.7.10.1) - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct’s, ‘Fibroblast Growth Factor Receptor 1 (Basic Fibroblast Growth Factor Receptor 1 or Fms Like Tyrosine Kinase 2 or N Sam or Proto Oncogene c Fgr or CD331 or FLT2 or FGFR1 or EC 2.7.10.1) - Pipeline Review, H2 2016’,...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0657TDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC0657TDB
  • View Report: Research and Experts Market Report: Neuroendocrine Tumors - Pipeline Review, H2 2016

    Neuroendocrine Tumors - Pipeline Review, H2 2016


    2016-12-14
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Neuroendocrine Tumors – Pipeline Review, H2 2016, provides an overview of the Neuroendocrine Tumors (Oncology) pipeline landscape.

    Neuroendocrine tumor begins...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8809IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8809IDB
  • View Report: Research and Experts Market Report: Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H2 2016

    Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H2 2016


    2016-12-14
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bile Duct Cancer (Cholangiocarcinoma) – Pipeline Review, H2 2016, provides an overview of the Bile Duct Cancer (Cholangiocarcinoma) (Oncology) pipeline landscape.

    Bi...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8808IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8808IDB
  • View Report: Research and Experts Market Report: Age Related Macular Degeneration - Pipeline Review, H2 2016

    Age Related Macular Degeneration - Pipeline Review, H2 2016


    2016-12-14
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Age Related Macular Degeneration – Pipeline Review, H2 2016, provides an overview of the Age Related Macular Degeneration (Ophthalmology) pipeline landscape.

    Age...

  • Market Report
  • Healthcare
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8804IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8804IDB
  • View Report: Research and Experts Market Report: Baculoviral IAP Repeat Containing Protein 5 (Apoptosis Inhibitor 4 or Apoptosis Inhibitor Survivin or BIRC5) - Pipeline Review, H2...

    Baculoviral IAP Repeat Containing Protein 5 (Apoptosis Inhibitor 4 or Apoptosis Inhibitor Survivin or BIRC5) - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct’s, ‘Baculoviral IAP Repeat Containing Protein 5 (Apoptosis Inhibitor 4 or Apoptosis Inhibitor Survivin or BIRC5) - Pipeline Review, H2 2016’, provides in depth analysis on Baculoviral IAP Repeat Containing Protein...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0651TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0651TDB
  • View Report: Research and Experts Market Report: Insulin Like Growth Factor II (Somatomedin A or T3M 11 Derived Growth Factor or IGF2) - Pipeline Review, H2 2016

    Insulin Like Growth Factor II (Somatomedin A or T3M 11 Derived Growth Factor or IGF2) - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct’s, ‘Insulin Like Growth Factor II (Somatomedin A or T3M 11 Derived Growth Factor or IGF2) - Pipeline Review, H2 2016’, provides in depth analysis on Insulin Like Growth Factor II (Somatomedin A or T3M 11 Derived Growth...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0648TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0648TDB
  • View Report: Research and Experts Market Report: Metastatic Breast Cancer - Pipeline Review, H2 2016

    Metastatic Breast Cancer - Pipeline Review, H2 2016


    2016-12-07
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Metastatic Breast Cancer - Pipeline Review, H2 2016, provides an overview of the Metastatic Breast Cancer (Oncology) pipeline landscape.

    Metastatic breast cancer...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8794IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8794IDB
  • View Report: Research and Experts Market Report: Dental Pain - Pipeline Review, H2 2016

    Dental Pain - Pipeline Review, H2 2016


    2016-12-07
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Dental Pain - Pipeline Review, H2 2016, provides an overview of the Dental Pain (Central Nervous System) pipeline landscape.

    A pain in the tooth is called dental...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8786IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC8786IDB
  • View Report: Research and Experts Market Report: Non-Hodgkin Lymphoma - Pipeline Review, H2 2016

    Non-Hodgkin Lymphoma - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Non-Hodgkin Lymphoma - Pipeline Review, H2 2016, provides an overview of the Non-Hodgkin Lymphoma (Oncology) pipeline landscape.

    Non-Hodgkin lymphoma (also known...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8759IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8759IDB
  • View Report: Research and Experts Market Report: Hepatocellular Carcinoma - Pipeline Review, H2 2016

    Hepatocellular Carcinoma - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hepatocellular Carcinoma - Pipeline Review, H2 2016, provides an overview of the Hepatocellular Carcinoma (Oncology) pipeline landscape.

    Hepatocellular carcinoma...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8748IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8748IDB
  • View Report: Research and Experts Company Report: Phibro Animal Health Corp (PAHC) - Financial and Strategic SWOT Analysis Review

    Phibro Animal Health Corp (PAHC) - Financial and Strategic SWOT Analysis Review


    2016-11-29
    Phibro Animal Health Corp (Phibro), a subsidiary of BFI Co., LLC, is a diversified animal health, and mineral nutrition company. It develops, manufactures and markets a broad range of animal health and nutritional products for a broad range of food animal...
  • Company Report
  • Life Sciences
  • United States
  • $125.00
  • Report 05IC-GDPH32199FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH32199FSA
  • View Report: Research and Experts Market Report: Receptor Tyrosine Protein Kinase ERBB 4 (Tyrosine Kinase Type Cell Surface Receptor HER4 or Proto Oncogene Like Protein c ErbB 4...

    Receptor Tyrosine Protein Kinase ERBB 4 (Tyrosine Kinase Type Cell Surface Receptor HER4 or Proto Oncogene Like Protein c ErbB 4 or p180erbB4 or HER4 or ERBB4 or EC 2.7.10.1) - Pipeline Review, H2 2016


    2016-10-31
    Global Markets Direct’s, ‘Receptor Tyrosine Protein Kinase ERBB 4 (Tyrosine Kinase Type Cell Surface Receptor HER4 or Proto Oncogene Like Protein c ErbB 4 or p180erbB4 or HER4 or ERBB4 or EC 2.7.10.1) - Pipeline Review, H2 2016’, provides...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0626TDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC0626TDB
  • View Report: Research and Experts Market Report: Meningioma - Pipeline Review, H2 2016

    Meningioma - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Meningioma – Pipeline Review, H2 2016, provides an overview of the Meningioma (Oncology) pipeline landscape.

    A meningioma is a type of tumor that develops from...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8741IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC8741IDB
  • View Report: Research and Experts Market Report: Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016

    Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Lymphocytic Leukemia (CLL) – Pipeline Review, H2 2016, provides an overview of the Chronic Lymphocytic Leukemia (CLL) (Oncology) pipeline landscape.

    Chronic...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8731IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8731IDB
  • View Report: Research and Experts Market Report: Myelodysplastic Syndrome - Pipeline Review, H2 2016

    Myelodysplastic Syndrome - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Myelodysplastic Syndrome – Pipeline Review, H2 2016, provides an overview of the Myelodysplastic Syndrome (Oncology) pipeline landscape.

    Myelodysplastic syndrome...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8729IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8729IDB
  • View Report: Research and Experts Market Report: Metastatic Colorectal Cancer - Pipeline Review, H2 2016

    Metastatic Colorectal Cancer - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Metastatic Colorectal Cancer – Pipeline Review, H2 2016, provides an overview of the Metastatic Colorectal Cancer (Oncology) pipeline landscape.

    Metastatic...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8728IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8728IDB
  • View Report: Research and Experts Market Report: Stroke - Pipeline Review, H2 2016

    Stroke - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Stroke – Pipeline Review, H2 2016, provides an overview of the Stroke (Cardiovascular) pipeline landscape.

    Stroke is a condition in which the brain cells suddenly...

  • Market Report
  • Cardiovascular
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8726IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8726IDB
  • View Report: Research and Experts Market Report: Follicular Lymphoma - Pipeline Review, H2 2016

    Follicular Lymphoma - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Follicular Lymphoma – Pipeline Review, H2 2016, provides an overview of the Follicular Lymphoma (Oncology) pipeline landscape.

    Follicular lymphoma is a common...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8717IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8717IDB
  • View Report: Research and Experts Market Report: Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2016

    Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer – Pipeline Review, H2 2016, provides an overview of the Metastatic...
  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8713IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8713IDB
  • View Report: Research and Experts Market Report: Epithelial Ovarian Cancer - Pipeline Review, H2 2016

    Epithelial Ovarian Cancer - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Epithelial Ovarian Cancer – Pipeline Review, H2 2016, provides an overview of the Epithelial Ovarian Cancer (Oncology) pipeline landscape.

    Ovarian epithelial...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8712IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8712IDB
  • View Report: Research and Experts Market Report: Small-Cell Lung Cancer - Pipeline Review, H2 2016

    Small-Cell Lung Cancer - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Small-Cell Lung Cancer – Pipeline Review, H2 2016, provides an overview of the Small-Cell Lung Cancer (Oncology) pipeline landscape.

    Small cell lung cancer...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8706IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8706IDB
  • View Report: Research and Experts Market Report: Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2016

    Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Refractory Acute Myeloid Leukemia – Pipeline Review, H2 2016, provides an overview of the Refractory Acute Myeloid Leukemia (Oncology) pipeline landscape.

    The...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8705IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8705IDB
  • View Report: Research and Experts Industry Report: Biotechnology in Europe

    Biotechnology in Europe


    2016-11-24
    Biotechnology in Europe industry profile provides top-line qualitative and quantitative summary information including: market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial...
  • Industry Report
  • Biotechnology
  • Europe
  • $350.00
  • Report 05IK-OHME8012 has a star rating of 4.3 out of 5
  • Go to More information on Report 05IK-OHME8012
  • View Report: Research and Experts Industry Report: Biotechnology in Germany

    Biotechnology in Germany


    2016-11-23
    Biotechnology in Germany industry profile provides top-line qualitative and quantitative summary information including: market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financia...
  • Industry Report
  • Biotechnology
  • Germany
  • $350.00
  • Report 05IK-OHME7995 has a star rating of 4.3 out of 5
  • Go to More information on Report 05IK-OHME7995
  • View Report: Research and Experts Project Profile: Boehringer Ingelheim GmbH - Strategy, SWOT and Corporate Finance Report

    Boehringer Ingelheim GmbH - Strategy, SWOT and Corporate Finance Report


    2017-01-31
    Boehringer Ingelheim GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio...
  • Project Profile
  • Life Sciences
  • Germany
  • $175.00
  • Report 05IK-1B7F64FA-9B0D-4D41-951B-E2 has a star rating of 4.2 out of 5
  • Go to More information on Report 05IK-1B7F64FA-9B0D-4D41-951B-E2
  • View Report: Research and Experts Market Report: Cervical Cancer - Pipeline Review, H2 2016

    Cervical Cancer - Pipeline Review, H2 2016


    2016-11-23
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cervical Cancer – Pipeline Review, H2 2016, provides an overview of the Cervical Cancer (Oncology) pipeline landscape.

    Cervical cancer occurs when abnormal...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8700IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8700IDB
  • View Report: Research and Experts Market Report: Malignant Pleural Mesothelioma - Pipeline Review, H2 2016

    Malignant Pleural Mesothelioma - Pipeline Review, H2 2016


    2016-11-23
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Malignant Pleural Mesothelioma – Pipeline Review, H2 2016, provides an overview of the Malignant Pleural Mesothelioma (Oncology) pipeline landscape.

    Malignant...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8690IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8690IDB
  • View Report: Research and Experts Market Report: Endometrial Cancer - Pipeline Review, H2 2016

    Endometrial Cancer - Pipeline Review, H2 2016


    2016-11-23
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Endometrial Cancer – Pipeline Review, H2 2016, provides an overview of the Endometrial Cancer (Oncology) pipeline landscape.

    Endometrial cancer is cancer that...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8689IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8689IDB
  • View Report: Research and Experts Market Report: Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H2 2016

    Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H2 2016


    2016-11-23
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Adenocarcinoma Of The Gastroesophageal Junction – Pipeline Review, H2 2016, provides an overview of the Adenocarcinoma Of The Gastroesophageal Junction (Oncology)...
  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8688IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8688IDB
  • View Report: Research and Experts Market Report: Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016

    Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016


    2016-11-23
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Refractory Chronic Lymphocytic Leukemia (CLL) – Pipeline Review, H2 2016, provides an overview of the Refractory Chronic Lymphocytic Leukemia (CLL) (Oncology)...
  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8687IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8687IDB
  • View Report: Research and Experts Market Report: Tumor Necrosis Factor Receptor Superfamily Member 5 (B Cell Surface Antigen CD40 or Bp50 or CDw40 or CD40L Receptor or TNFRSF5 or...

    Tumor Necrosis Factor Receptor Superfamily Member 5 (B Cell Surface Antigen CD40 or Bp50 or CDw40 or CD40L Receptor or TNFRSF5 or CD40) - Pipeline Review, H2 2016


    2016-10-19
    Global Markets Direct’s, ‘Tumor Necrosis Factor Receptor Superfamily Member 5 (B Cell Surface Antigen CD40 or Bp50 or CDw40 or CD40L Receptor or TNFRSF5 or CD40) - Pipeline Review, H2 2016’, provides in depth analysis on Tumor Necrosis...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0587TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0587TDB
  • View Report: Research and Experts Market Report: Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H2 2016

    Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Type 1 Diabetes (Juvenile Diabetes) – Pipeline Review, H2 2016, provides an overview of the Type 1 Diabetes (Juvenile Diabetes) (Metabolic Disorders) pipeline...
  • Market Report
  • Metabolic Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8770IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8770IDB
  • View Report: Research and Experts Market Report: Renal Cell Carcinoma - Pipeline Review, H2 2016

    Renal Cell Carcinoma - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Renal Cell Carcinoma – Pipeline Review, H2 2016, provides an overview of the Renal Cell Carcinoma (Oncology) pipeline landscape.

    Renal cell carcinoma (RCC,...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8682IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8682IDB
  • View Report: Research and Experts Market Report: Thrombocytopenia - Pipeline Review, H2 2016

    Thrombocytopenia - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Thrombocytopenia – Pipeline Review, H2 2016, provides an overview of the Thrombocytopenia (Hematological Disorders) pipeline landscape.

    Thrombocytopenia is...

  • Market Report
  • Hematological Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8676IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8676IDB
  • View Report: Research and Experts Market Report: Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016

    Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Relapsed Chronic Lymphocytic Leukemia (CLL) – Pipeline Review, H2 2016, provides an overview of the Relapsed Chronic Lymphocytic Leukemia (CLL) (Oncology) pipeline...
  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8673IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8673IDB
  • View Report: Research and Experts Market Report: Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H2 2016

    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Lymphocytic Leukemia – Pipeline Review, H2 2016, provides an overview of the Acute Lymphocytic Leukemia (Oncology) pipeline landscape.

    Acute lymphocytic...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8640IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8640IDB
  • View Report: Research and Experts Market Report: Systemic Lupus Erythematosus - Pipeline Review, H2 2016

    Systemic Lupus Erythematosus - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Systemic Lupus Erythematosus – Pipeline Review, H2 2016, provides an overview of the Systemic Lupus Erythematosus (Immunology) pipeline landscape.

    Systemic...

  • Market Report
  • Immunology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8637IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8637IDB
  • View Report: Research and Experts Market Report: Schizophrenia - Pipeline Review, H2 2016

    Schizophrenia - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Schizophrenia – Pipeline Review, H2 2016, provides an overview of the Schizophrenia (Central Nervous System) pipeline landscape.

    Schizophrenia is a chronic,...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8727IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8727IDB
  • View Report: Research and Experts Market Report: Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2016

    Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Head And Neck Cancer Squamous Cell Carcinoma – Pipeline Review, H2 2016, provides an overview of the Head And Neck Cancer Squamous Cell Carcinoma (Oncology)...
  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8644IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8644IDB
  • View Report: Research and Experts Market Report: Anaplastic Astrocytoma - Pipeline Review, H2 2016

    Anaplastic Astrocytoma - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Anaplastic Astrocytoma – Pipeline Review, H2 2016, provides an overview of the Anaplastic Astrocytoma (Oncology) pipeline landscape.

    Anaplastic astrocytoma...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8632IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC8632IDB
  • View Report: Research and Experts Market Report: Burkitt Lymphoma - Pipeline Review, H2 2016

    Burkitt Lymphoma - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Burkitt Lymphoma – Pipeline Review, H2 2016, provides an overview of the Burkitt Lymphoma (Oncology) pipeline landscape.

    Burkitt lymphoma is a form of non-Hodgkin�...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8631IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC8631IDB
  • View Report: Research and Experts Market Report: Bladder Cancer - Pipeline Review, H2 2016

    Bladder Cancer - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bladder Cancer – Pipeline Review, H2 2016, provides an overview of the Bladder Cancer (Oncology) pipeline landscape.

    Bladder cancer occurs in tissues of the...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8622IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8622IDB
  • View Report: Research and Experts Market Report: Obesity - Pipeline Review, H2 2016

    Obesity - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Obesity – Pipeline Review, H2 2016, provides an overview of the Obesity (Metabolic Disorders) pipeline landscape.

    Obesity is defined as having an excessive...

  • Market Report
  • Metabolic Disorders
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8621IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8621IDB
  • View Report: Research and Experts Market Report: Type 2 Diabetes - Pipeline Review, H2 2016

    Type 2 Diabetes - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Type 2 Diabetes – Pipeline Review, H2 2016, provides an overview of the Type 2 Diabetes (Metabolic Disorders) pipeline landscape.

    Type 2 diabetes is a chronic...

  • Market Report
  • Metabolic Disorders
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8585IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8585IDB
  • View Report: Research and Experts Market Report: Cytochrome P450 11B2 Mitochondrial (Aldosterone Synthase or Cytochrome P450Aldo or Cytochrome P450C18 or Steroid 18 Hydroxylase or...

    Cytochrome P450 11B2 Mitochondrial (Aldosterone Synthase or Cytochrome P450Aldo or Cytochrome P450C18 or Steroid 18 Hydroxylase or CYP11B2 or EC 1.14.15.4 or EC 1.14.15.5) - Pipeline Review, H2 2016


    2016-09-30
    Global Markets Direct’s, ‘Cytochrome P450 11B2 Mitochondrial (Aldosterone Synthase or Cytochrome P450Aldo or Cytochrome P450C18 or Steroid 18 Hydroxylase or CYP11B2 or EC 1.14.15.4 or EC 1.14.15.5) - Pipeline Review, H2 2016’, provides...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0560TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0560TDB
  • View Report: Research and Experts Market Report: Diffuse Large B-Cell Lymphoma - Pipeline Review, H2 2016

    Diffuse Large B-Cell Lymphoma - Pipeline Review, H2 2016


    2016-10-29
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diffuse Large B-Cell Lymphoma – Pipeline Review, H2 2016, provides an overview of the Diffuse Large B-Cell Lymphoma (Oncology) pipeline landscape.

    Diffuse large...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8656IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8656IDB
  • View Report: Research and Experts Market Report: Low Back Pain - Pipeline Review, H2 2016

    Low Back Pain - Pipeline Review, H2 2016


    2016-10-29
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Low Back Pain – Pipeline Review, H2 2016, provides an overview of the Low Back Pain (Central Nervous System) pipeline landscape.

    Low back pain can happen anywhere...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8615IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC8615IDB
  • View Report: Research and Experts Market Report: B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2016

    B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2016


    2016-10-29
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide B-Cell Non-Hodgkin Lymphoma – Pipeline Review, H2 2016, provides an overview of the B-Cell Non-Hodgkin Lymphoma (Oncology) pipeline landscape.

    Non-Hodgkin lymphoma...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8609IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8609IDB
  • View Report: Research and Experts Market Report: Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2016

    Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2016


    2016-10-29
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Relapsed Acute Myeloid Leukemia – Pipeline Review, H2 2016, provides an overview of the Relapsed Acute Myeloid Leukemia (Oncology) pipeline landscape.

    Return...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8605IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8605IDB
  • View Report: Research and Experts Market Report: Osteoarthritis Pain - Pipeline Review, H2 2016

    Osteoarthritis Pain - Pipeline Review, H2 2016


    2016-10-29
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteoarthritis Pain – Pipeline Review, H2 2016, provides an overview of the Osteoarthritis Pain (Central Nervous System) pipeline landscape.

    Osteoarthritis...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8600IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8600IDB
  • View Report: Research and Experts Market Report: Fallopian Tube Cancer - Pipeline Review, H2 2016

    Fallopian Tube Cancer - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Fallopian Tube Cancer – Pipeline Review, H2 2016, provides an overview of the Fallopian Tube Cancer (Oncology) pipeline landscape.

    Fallopian tube cancer is...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8595IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8595IDB
  • View Report: Research and Experts Market Report: Dementia Associated With Alzheimer

    Dementia Associated With Alzheimer's Disease - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Dementia Associated With Alzheimer's Disease – Pipeline Review, H2 2016, provides an overview of the Dementia Associated With Alzheimer's Disease (Central...
  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8589IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC8589IDB
  • View Report: Research and Experts Market Report: Head And Neck Cancer - Pipeline Review, H2 2016

    Head And Neck Cancer - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Head And Neck Cancer – Pipeline Review, H2 2016, provides an overview of the Head And Neck Cancer (Oncology) pipeline landscape.

    Head and Neck Cancer is a cancer...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8588IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8588IDB
  • View Report: Research and Experts Market Report: Gastric Cancer - Pipeline Review, H2 2016

    Gastric Cancer - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gastric Cancer – Pipeline Review, H2 2016, provides an overview of the Gastric Cancer (Oncology) pipeline landscape.

    Gastric cancer, also called stomach cancer,...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8584IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8584IDB
  • View Report: Research and Experts Market Report: Asthma - Pipeline Review, H2 2016

    Asthma - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Asthma – Pipeline Review, H2 2016, provides an overview of the Asthma (Respiratory) pipeline landscape.

    Asthma is a chronic disease involving the airways in...

  • Market Report
  • Respiratory
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8567IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8567IDB
  • View Report: Research and Experts Market Report: Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2016

    Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2016


    2016-10-19
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Recurrent Glioblastoma Multiforme (GBM) – Pipeline Review, H2 2016, provides an overview of the Recurrent Glioblastoma Multiforme (GBM) (Oncology) pipeline landscape....
  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8562IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8562IDB
  • View Report: Research and Experts Market Report: Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H2 2016

    Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H2 2016


    2016-10-19
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Plaque Psoriasis (Psoriasis Vulgaris) – Pipeline Review, H2 2016, provides an overview of the Plaque Psoriasis (Psoriasis Vulgaris) (Immunology) pipeline landscape.

    ...

  • Market Report
  • Immunology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8559IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8559IDB
  • View Report: Research and Experts Market Report: Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, H2 2016

    Chronic Kidney Disease (Chronic Renal Failure) - Pipeline Review, H2 2016


    2016-10-19
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Kidney Disease (Chronic Renal Failure) – Pipeline Review, H2 2016, provides an overview of the Chronic Kidney Disease (Chronic Renal Failure) (Genito...
  • Market Report
  • Healthcare
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8538IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8538IDB
  • View Report: Research and Experts Market Report: Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2016

    Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H2 2016


    2016-10-12
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Obstructive Pulmonary Disease (COPD) – Pipeline Review, H2 2016, provides an overview of the Chronic Obstructive Pulmonary Disease (COPD) (Respiratory)...
  • Market Report
  • Respiratory
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8528IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8528IDB
  • View Report: Research and Experts Market Report: Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2016

    Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2016


    2016-10-12
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hormone Refractory Prostate Cancer – Pipeline Review, H2 2016, provides an overview of the Hormone Refractory Prostate Cancer (Oncology) pipeline landscape.

    Prostate...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8504IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8504IDB
  • View Report: Research and Experts Market Report: Hepatitis C - Pipeline Review, H2 2016

    Hepatitis C - Pipeline Review, H2 2016


    2016-09-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hepatitis C – Pipeline Review, H2 2016, provides an overview of the Hepatitis C (Infectious Disease) pipeline landscape.

    Hepatitis C is a contagious viral infection...

  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8516IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8516IDB
  • View Report: Research and Experts Market Report: Rhabdomyosarcoma - Pipeline Review, H2 2016

    Rhabdomyosarcoma - Pipeline Review, H2 2016


    2016-09-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Rhabdomyosarcoma – Pipeline Review, H2 2016, provides an overview of the Rhabdomyosarcoma (Oncology) pipeline landscape.

    Rhabdomyosarcoma (RMS) is a malignant...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8513IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8513IDB
  • View Report: Research and Experts Market Report: Somatostatin Receptor Type 2 (SRIF1 or SSTR2) - Pipeline Review, H2 2016

    Somatostatin Receptor Type 2 (SRIF1 or SSTR2) - Pipeline Review, H2 2016


    2016-09-28
    Global Markets Direct’s, ‘Somatostatin Receptor Type 2 (SRIF1 or SSTR2) - Pipeline Review, H2 2016’, provides in depth analysis on Somatostatin Receptor Type 2 (SRIF1 or SSTR2) targeted pipeline therapeutics.

    The report provides comprehensive...

  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0546TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0546TDB
  • View Report: Research and Experts Market Report: Hypersensitivity - Pipeline Review, H2 2016

    Hypersensitivity - Pipeline Review, H2 2016


    2016-09-28
    Global Markets Direct’s, ‘Hypersensitivity - Pipeline Review, H2 2016’, provides an overview of the Hypersensitivity pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Hypersensitivity,...

  • Market Report
  • Immunology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8499IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8499IDB
  • View Report: Research and Experts Market Report: Psoriasis - Pipeline Review, H2 2016

    Psoriasis - Pipeline Review, H2 2016


    2016-09-28
    Global Markets Direct’s, ‘Psoriasis - Pipeline Review, H2 2016’, provides an overview of the Psoriasis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Psoriasis, complete with...

  • Market Report
  • Immunology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8494IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8494IDB
  • View Report: Research and Experts Market Report: Lupus Nephritis - Pipeline Review, H2 2016

    Lupus Nephritis - Pipeline Review, H2 2016


    2016-09-28
    Global Markets Direct’s, ‘Lupus Nephritis - Pipeline Review, H2 2016’, provides an overview of the Lupus Nephritis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Lupus Nephritis,...

  • Market Report
  • Immunology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8490IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8490IDB
  • View Report: Research and Experts Market Report: Cystic Fibrosis - Pipeline Review, H2 2016

    Cystic Fibrosis - Pipeline Review, H2 2016


    2016-09-28
    Global Markets Direct’s, ‘Cystic Fibrosis - Pipeline Review, H2 2016’, provides an overview of the Cystic Fibrosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Cystic Fibrosis,...

  • Market Report
  • Respiratory
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8474IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8474IDB
  • View Report: Research and Experts Market Report: Metastatic Melanoma - Pipeline Review, H2 2016

    Metastatic Melanoma - Pipeline Review, H2 2016


    2016-09-28
    Global Markets Direct’s, ‘Metastatic Melanoma - Pipeline Review, H2 2016’, provides an overview of the Metastatic Melanoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Metastatic...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8473IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8473IDB
  • View Report: Research and Experts Industry Report: OTC Pharmaceuticals in the Netherlands

    OTC Pharmaceuticals in the Netherlands


    2016-09-27
    OTC Pharmaceuticals in the Netherlands industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading...
  • Industry Report
  • Pharmaceuticals
  • Netherlands
  • $350.00
  • Report 05IK-OHME7291 has a star rating of 4.2 out of 5
  • Go to More information on Report 05IK-OHME7291
  • View Report: Research and Experts Industry Report: OTC Pharmaceuticals in Italy

    OTC Pharmaceuticals in Italy


    2016-09-27
    OTC Pharmaceuticals in Italy industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players...
  • Industry Report
  • Pharmaceuticals
  • Italy
  • $350.00
  • Report 05IK-OHME7290 has a star rating of 4.3 out of 5
  • Go to More information on Report 05IK-OHME7290
  • View Report: Research and Experts Industry Report: Pharmaceuticals in Germany

    Pharmaceuticals in Germany


    2016-09-26
    Pharmaceuticals in Germany industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players includ...
  • Industry Report
  • Pharmaceuticals
  • Germany
  • $350.00
  • Report 05IK-OHME7227 has a star rating of 4.2 out of 5
  • Go to More information on Report 05IK-OHME7227
  • View Report: Research and Experts Market Report: Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H2 2016

    Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H2 2016


    2016-08-31
    Global Markets Direct’s, ‘Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H2 2016’, provides an overview of the Peripheral T-Cell Lymphomas (PTCL) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8436IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8436IDB
  • View Report: Research and Experts Market Report: Anxiety Disorders - Pipeline Review, H2 2016

    Anxiety Disorders - Pipeline Review, H2 2016


    2016-08-31
    Global Markets Direct’s, ‘Anxiety Disorders - Pipeline Review, H2 2016’, provides an overview of the Anxiety Disorders pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Anxiety...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8433IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8433IDB
  • View Report: Research and Experts Company Report: MagForce AG (MF6) - Product Pipeline Analysis, 2016 Update

    MagForce AG (MF6) - Product Pipeline Analysis, 2016 Update


    2016-08-24
    MagForce AG (MagForce) is a healthcare service provider that offers nanotechnology-based cancer treatment. The company offers treatment for brain tumor, and cancer diseases. Its products include NanoActivator, NanoTherm, NanoPlan, and NanoTherm Therapy....
  • Company Report
  • Medical Devices
  • Germany
  • $750.00
  • Report 05IC-GDME7894PD has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDME7894PD
  • View Report: Research and Experts Market Report: GTPase KRas (KRas 2 or Ki Ras or c K Ras or KRAS or EC 3.6.5.2) - Pipeline Review, H2 2016

    GTPase KRas (KRas 2 or Ki Ras or c K Ras or KRAS or EC 3.6.5.2) - Pipeline Review, H2 2016


    2016-08-31
    Global Markets Direct’s, ‘GTPase KRas (KRas 2 or Ki Ras or c K Ras or KRAS or EC 3.6.5.2) - Pipeline Review, H2 2016’, provides in depth analysis on GTPase KRas (KRas 2 or Ki Ras or c K Ras or KRAS or EC 3.6.5.2) targeted pipeline therapeutics....
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0493TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0493TDB
  • View Report: Research and Experts Market Report: Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H2 2016

    Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H2 2016


    2016-08-31
    Global Markets Direct’s, ‘Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H2 2016’, provides an overview of the Metastatic Adenocarcinoma of The Pancreas pipeline landscape.

    The report provides comprehensive information on...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8420IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8420IDB
  • View Report: Research and Experts Market Report: Rhinovirus Infections - Pipeline Review, H2 2016

    Rhinovirus Infections - Pipeline Review, H2 2016


    2016-08-24
    Global Markets Direct’s, ‘Rhinovirus Infections - Pipeline Review, H2 2016’, provides an overview of the Rhinovirus Infections pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8398IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC8398IDB
  • View Report: Research and Experts Market Report: Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H2 2016

    Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H2 2016


    2016-08-24
    Global Markets Direct’s, ‘Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H2 2016’, provides an overview of the Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) pipeline landscape....
  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8392IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC8392IDB
  • View Report: Research and Experts Market Report: Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H2 2016

    Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H2 2016


    2016-08-24
    Global Markets Direct’s, ‘Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H2 2016’, provides an overview of the Wet (Neovascular / Exudative) Macular Degeneration pipeline landscape.

    The report provides comprehensive...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8376IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8376IDB
  • View Report: Research and Experts Market Report: Medullary Thyroid Cancer - Pipeline Review, H2 2016

    Medullary Thyroid Cancer - Pipeline Review, H2 2016


    2016-08-17
    Global Markets Direct’s, ‘Medullary Thyroid Cancer - Pipeline Review, H2 2016’, provides an overview of the Medullary Thyroid Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8369IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC8369IDB
  • View Report: Research and Experts Market Report: Alzheimer

    Alzheimer's Disease - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Alzheimer's Disease - Pipeline Review, H2 2016’, provides an overview of the Alzheimer's Disease pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8356IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8356IDB
  • View Report: Research and Experts Market Report: Diabetic Nephropathy - Pipeline Review, H2 2016

    Diabetic Nephropathy - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Diabetic Nephropathy - Pipeline Review, H2 2016’, provides an overview of the Diabetic Nephropathy pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Diabetic...

  • Market Report
  • Metabolic Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8347IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8347IDB
  • View Report: Research and Experts Market Report: Dementia - Pipeline Review, H2 2016

    Dementia - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Dementia - Pipeline Review, H2 2016’, provides an overview of the Dementia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Dementia, complete with analysis...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8345IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8345IDB
  • View Report: Research and Experts Market Report: Indolent Lymphoma - Pipeline Review, H2 2016

    Indolent Lymphoma - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Indolent Lymphoma - Pipeline Review, H2 2016’, provides an overview of the Indolent Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Indolent...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8340IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8340IDB
  • View Report: Research and Experts Market Report: Angiopoietin 2 (Ang 2 or ANGPT2) - Pipeline Review, H2 2016

    Angiopoietin 2 (Ang 2 or ANGPT2) - Pipeline Review, H2 2016


    2016-07-27
    ‘Angiopoietin 2 (Ang 2 or ANGPT2) - Pipeline Review, H2 2016’, provides in depth analysis on Angiopoietin 2 (Ang 2 or ANGPT2) targeted pipeline therapeutics.

    The report provides comprehensive information on the Angiopoietin 2 (Ang 2 or ANGPT2),...

  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0411TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0411TDB
  • View Report: Research and Experts Market Report: Tyrosine Protein Kinase Lyn (Lck/Yes Related Novel Protein Tyrosine Kinase or V Yes 1 Yamaguchi Sarcoma Viral Related Oncogene Homolog...

    Tyrosine Protein Kinase Lyn (Lck/Yes Related Novel Protein Tyrosine Kinase or V Yes 1 Yamaguchi Sarcoma Viral Related Oncogene Homolog or p53Lyn or p56Lyn or LYN or EC 2.7.10.2) - Pipeline Review, H2 2016


    2016-07-20
    ‘Tyrosine Protein Kinase Lyn (Lck/Yes Related Novel Protein Tyrosine Kinase or V Yes 1 Yamaguchi Sarcoma Viral Related Oncogene Homolog or p53Lyn or p56Lyn or LYN or EC 2.7.10.2) - Pipeline Review, H2 2016’, provides in depth analysis on Tyrosine...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0403TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0403TDB
  • View Report: Research and Experts Market Report: Focal Adhesion Kinase (FAK or EC 2.7.10.2) - Pipeline Review, H2 2016

    Focal Adhesion Kinase (FAK or EC 2.7.10.2) - Pipeline Review, H2 2016


    2016-07-20
    ‘Focal Adhesion Kinase (FAK or EC 2.7.10.2) - Pipeline Review, H2 2016’, provides in depth analysis on Focal Adhesion Kinase (FAK or EC 2.7.10.2) targeted pipeline therapeutics.

    The report provides comprehensive information on the Focal Adhesion...

  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0397TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0397TDB
  • View Report: Research and Experts Market Report: Serine/Threonine Protein Kinase PLK1 (Polo Like Kinase 1 or Serine/Threonine Protein Kinase 13 or PLK1 or EC 2.7.11.21) - Pipeline...

    Serine/Threonine Protein Kinase PLK1 (Polo Like Kinase 1 or Serine/Threonine Protein Kinase 13 or PLK1 or EC 2.7.11.21) - Pipeline Review, H2 2016


    2016-07-20
    ‘Serine/Threonine Protein Kinase PLK1 (Polo Like Kinase 1 or Serine/Threonine Protein Kinase 13 or PLK1 or EC 2.7.11.21) - Pipeline Review, H2 2016’, provides in depth analysis on Serine/Threonine Protein Kinase PLK1 (Polo Like Kinase 1 or Serine/Threonin...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0395TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0395TDB
  • View Report: Research and Experts Market Report: Diabetic Macular Edema - Pipeline Review, H2 2016

    Diabetic Macular Edema - Pipeline Review, H2 2016


    2016-07-20
    ‘Diabetic Macular Edema - Pipeline Review, H2 2016’, provides an overview of the Diabetic Macular Edema pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Diabetic Macular Edema, complete...

  • Market Report
  • Metabolic Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8286IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8286IDB
  • View Report: Research and Experts Market Report: Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2016

    Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2016


    2016-07-27
    ‘Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2016’, provides an overview of the Systemic Sclerosis (Scleroderma) pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Systemic...

  • Market Report
  • Healthcare
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8302IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8302IDB
  • View Report: Research and Experts Market Report: Non-Alcoholic Steatohepatitis - Pipeline Review, H2 2016

    Non-Alcoholic Steatohepatitis - Pipeline Review, H2 2016


    2016-07-20
    ‘Non-Alcoholic Steatohepatitis - Pipeline Review, H2 2016’, provides an overview of the Non-Alcoholic Steatohepatitis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Non-Alcoholic...

  • Market Report
  • Healthcare
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8327IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8327IDB
  • View Report: Research and Experts Market Report: Tyrosine Protein Kinase Lck (Leukocyte C Terminal Src Kinase or Protein YT16 or Proto Oncogene Lck or T Cell Specific Protein Tyrosine...

    Tyrosine Protein Kinase Lck (Leukocyte C Terminal Src Kinase or Protein YT16 or Proto Oncogene Lck or T Cell Specific Protein Tyrosine Kinase or Lymphocyte Cell Specific Protein Tyrosine Kinase or p56 LCK or LCK or EC 2.7.10.2) - Pipeline Review, H2 2016


    2016-07-13
    Global Markets Direct’s, ‘Tyrosine Protein Kinase Lck (Leukocyte C Terminal Src Kinase or Protein YT16 or Proto Oncogene Lck or T Cell Specific Protein Tyrosine Kinase or Lymphocyte Cell Specific Protein Tyrosine Kinase or p56 LCK or LCK or...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0383TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0383TDB
  • View Report: Research and Experts Market Report: Sepsis - Pipeline Review, H2 2016

    Sepsis - Pipeline Review, H2 2016


    2016-07-13
    Global Markets Direct’s, ‘Sepsis - Pipeline Review, H2 2016’, provides an overview of the Sepsis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Sepsis, complete with analysis...

  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8220IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8220IDB
  • View Report: Research and Experts Market Report: Hyperalgesia - Pipeline Review, H2 2016

    Hyperalgesia - Pipeline Review, H2 2016


    2016-07-13
    Global Markets Direct’s, ‘Hyperalgesia - Pipeline Review, H2 2016’, provides an overview of the Hyperalgesia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Hyperalgesia, complete...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8224IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC8224IDB
  • View Report: Research and Experts Market Report: Post-Operative Pain - Pipeline Review, H2 2016

    Post-Operative Pain - Pipeline Review, H2 2016


    2016-07-13
    Global Markets Direct’s, ‘Post-Operative Pain - Pipeline Review, H2 2016’, provides an overview of the Post-Operative Pain pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Post-Operative...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8219IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8219IDB
  • View Report: Research and Experts Market Report: Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) - Pipeline Review, H1 2016

    Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) - Pipeline Review, H1 2016’, provides in depth analysis on Soluble Guanylate Cyclase (sGC or EC 4.6.1.2) targeted pipeline therapeutics.

    The report provides comprehensive...

  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0322TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0322TDB
  • View Report: Research and Experts Market Report: Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) - Pipeline Review, H1 2016

    Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) - Pipeline Review, H1 2016’, provides in depth analysis on Insulin Like Growth Factor 1 Receptor (CD221 or IGF1R or EC 2.7.10.1) targeted pipeline...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0228TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0228TDB
  • View Report: Research and Experts Market Report: Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) - Pipeline...

    Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Fibroblast Growth Factor Receptor 3 (Tyrosine Kinase JTK4 or Hydroxyaryl Protein Kinase or CD333 or FGFR3 or EC 2.7.10.1) - Pipeline Review, H1 2016’, provides in depth analysis on Fibroblast Growth Factor Receptor...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0225TDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC0225TDB
  • View Report: Research and Experts Market Report: Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) - Pipeline...

    Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Fibroblast Growth Factor Receptor 2 (Keratinocyte Growth Factor Receptor or K Sam or KGFR or CD332 or FGFR2 or EC 2.7.10.1) - Pipeline Review, H1 2016’, provides in depth analysis on Fibroblast Growth Factor Receptor...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0224TDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC0224TDB
  • View Report: Research and Experts Market Report: Fibroblast Growth Factor Receptor 1 (Basic Fibroblast Growth Factor Receptor 1 or Fms Like Tyrosine Kinase 2 or Proto Oncogene c...

    Fibroblast Growth Factor Receptor 1 (Basic Fibroblast Growth Factor Receptor 1 or Fms Like Tyrosine Kinase 2 or Proto Oncogene c Fgr or CD331 or FLT2 or FGFR1 or EC 2.7.10.1) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Fibroblast Growth Factor Receptor 1 (Basic Fibroblast Growth Factor Receptor 1 or Fms Like Tyrosine Kinase 2 or Proto Oncogene c Fgr or CD331 or FLT2 or FGFR1 or EC 2.7.10.1) - Pipeline Review, H1 2016’, provides...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0223TDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC0223TDB
  • View Report: Research and Experts Market Report: Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2016

    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2016’, provides an overview of the Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) pipeline landscape.

    The report...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7960IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7960IDB
  • View Report: Research and Experts Market Report: Colorectal Cancer - Pipeline Review, H1 2016

    Colorectal Cancer - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Colorectal Cancer - Pipeline Review, H1 2016’, provides an overview of the Colorectal Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Colorectal...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7959IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7959IDB
  • View Report: Research and Experts Market Report: HIV / AIDS - Pipeline Review, H1 2016

    HIV / AIDS - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘HIV / AIDS - Pipeline Review, H1 2016’, provides an overview of the HIV / AIDS pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for HIV / AIDS, complete...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7958IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7958IDB
  • View Report: Research and Experts Market Report: Melanoma - Pipeline Review, H1 2016

    Melanoma - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Melanoma - Pipeline Review, H1 2016’, provides an overview of the Melanoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Melanoma, complete with analysis...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7955IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7955IDB
  • View Report: Research and Experts Market Report: Breast Cancer - Pipeline Review, H1 2016

    Breast Cancer - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Breast Cancer - Pipeline Review, H1 2016’, provides an overview of the Breast Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Breast Cancer,...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7666IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7666IDB
  • View Report: Research and Experts Market Report: Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY-ESO-1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2...

    Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY-ESO-1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A) - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY-ESO-1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A) - Pipeline Review, H1 2016’, provides in depth analysis on Cancer/Testis...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0157TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0157TDB
  • View Report: Research and Experts Market Report: Mucin 1 (MUC-1 or Breast Carcinoma-Associated Antigen DF3 or Carcinoma-Associated Mucin or CD227) - Pipeline Review, H1 2016

    Mucin 1 (MUC-1 or Breast Carcinoma-Associated Antigen DF3 or Carcinoma-Associated Mucin or CD227) - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Mucin 1 (MUC-1 or Breast Carcinoma-Associated Antigen DF3 or Carcinoma-Associated Mucin or CD227) - Pipeline Review, H1 2016’, provides in depth analysis on Mucin 1 (MUC-1 or Breast Carcinoma-Associated Antigen...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0145TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0145TDB
  • View Report: Research and Experts Market Report: Baculoviral IAP Repeat-Containing Protein 5 (Apoptosis Inhibitor 4 or Apoptosis Inhibitor Survivin or BIRC5) - Pipeline Review, H1...

    Baculoviral IAP Repeat-Containing Protein 5 (Apoptosis Inhibitor 4 or Apoptosis Inhibitor Survivin or BIRC5) - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Baculoviral IAP Repeat-Containing Protein 5 (Apoptosis Inhibitor 4 or Apoptosis Inhibitor Survivin or BIRC5) - Pipeline Review, H1 2016’, provides in depth analysis on Baculoviral IAP Repeat-Containing Protein...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0144TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0144TDB
  • View Report: Research and Experts Market Report: Insulin Like Growth Factor 2 (Somatomedin-A or IGF-2) - Pipeline Review, H1 2016

    Insulin Like Growth Factor 2 (Somatomedin-A or IGF-2) - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Insulin Like Growth Factor 2 (Somatomedin-A or IGF-2) - Pipeline Review, H1 2016’, provides in depth analysis on Insulin Like Growth Factor 2 (Somatomedin-A or IGF-2) targeted pipeline therapeutics.

    The report...

  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0132TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0132TDB
  • View Report: Research and Experts Market Report: Insulin Like Growth Factor 1 (Mechano Growth Factor or Somatomedin-C or IGF-1) - Pipeline Review, H1 2016

    Insulin Like Growth Factor 1 (Mechano Growth Factor or Somatomedin-C or IGF-1) - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Insulin Like Growth Factor 1 (Mechano Growth Factor or Somatomedin-C or IGF-1) - Pipeline Review, H1 2016’, provides in depth analysis on Insulin Like Growth Factor 1 (Mechano Growth Factor or Somatomedin-C or...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0131TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0131TDB
  • View Report: Research and Experts Market Report: Rheumatoid Arthritis - Pipeline Review, H1 2016

    Rheumatoid Arthritis - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Rheumatoid Arthritis - Pipeline Review, H1 2016’, provides an overview of the Rheumatoid Arthritis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Rheumatoid...

  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7957IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7957IDB
  • View Report: Research and Experts Market Report: Ovarian Cancer - Pipeline Review, H1 2016

    Ovarian Cancer - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Ovarian Cancer - Pipeline Review, H1 2016’, provides an overview of the Ovarian Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Ovarian Cancer,...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7956IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7956IDB
  • View Report: Research and Experts Market Report: Non-Small Cell Lung Cancer - Pipeline Review, H1 2016

    Non-Small Cell Lung Cancer - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Non-Small Cell Lung Cancer - Pipeline Review, H1 2016’, provides an overview of the Non-Small Cell Lung Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7954IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7954IDB
  • View Report: Research and Experts Market Report: Pancreatic Cancer - Pipeline Review, H1 2016

    Pancreatic Cancer - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Pancreatic Cancer - Pipeline Review, H1 2016’, provides an overview of the Pancreatic Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Pancreatic...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7953IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7953IDB
  • View Report: Research and Experts Market Report: Prostate Cancer - Pipeline Review, H1 2016

    Prostate Cancer - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Prostate Cancer - Pipeline Review, H1 2016’, provides an overview of the Prostate Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Prostate Cancer,...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7952IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7952IDB
  • View Report: Research and Experts Market Report: Biologics

    Biologics


    2016-04-01
    Global Biologics value market is projected to grow about 9% compounded annually from 2010 through 2022. North America is projected to occupy about 50% of the total global market. Blood and blood products are the major product area with tremendous potentia...
  • Market Report
  • Healthcare
  • Global
  • $4,500.00
  • Report 05HF-MIR039 has a star rating of 4.9 out of 5
  • Go to More information on Report 05HF-MIR039
  • View Report: Research and Experts Market Report: Veterinary Vaccines

    Veterinary Vaccines


    2016-04-01
    The potential of vaccines to improve efficiency of growth, immunity towards diseases, and to lower the rate of mortality became a critical factor in prevention of diseases. The global Veterinary Vaccines market is rapidly growing at a CAGR of more than...
  • Market Report
  • Healthcare
  • Global
  • $3,600.00
  • Report 05HF-MIR021 has a star rating of 5.0 out of 5
  • Go to More information on Report 05HF-MIR021
  • View Report: Research and Experts Market Report: Receptor Tyrosine Protein Kinase ERBB 4 (Tyrosine Kinase Type Cell Surface Receptor HER4 or Proto Oncogene Like Protein c ErbB 4...

    Receptor Tyrosine Protein Kinase ERBB 4 (Tyrosine Kinase Type Cell Surface Receptor HER4 or Proto Oncogene Like Protein c ErbB 4 or p180erbB4 or HER4 or ERBB4 or EC 2.7.10.1) - Pipeline Review, H1 2016


    2016-06-22
    Global Markets Direct’s, ‘Receptor Tyrosine Protein Kinase ERBB 4 (Tyrosine Kinase Type Cell Surface Receptor HER4 or Proto Oncogene Like Protein c ErbB 4 or p180erbB4 or HER4 or ERBB4 or EC 2.7.10.1) - Pipeline Review, H1 2016’, provides...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0222TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0222TDB
  • View Report: Research and Experts Market Report: Liver Cancer - Pipeline Review, H1 2016

    Liver Cancer - Pipeline Review, H1 2016


    2016-06-22
    Global Markets Direct’s, ‘Liver Cancer - Pipeline Review, H1 2016’, provides an overview of the Liver Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Liver Cancer, complete...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7964IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7964IDB
  • View Report: Research and Experts Market Report: Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016

    Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016


    2016-06-22
    Global Markets Direct’s, ‘Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016’, provides an overview of the Glioblastoma Multiforme (GBM) pipeline landscape.

    The report provides comprehensive information on the therapeutics under...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7963IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7963IDB
  • View Report: Research and Experts Market Report: Tumor Necrosis Factor Receptor Superfamily Member 5 (B-Cell Surface Antigen CD40 or CD40L Receptor or CD40) - Pipeline Review, H1...

    Tumor Necrosis Factor Receptor Superfamily Member 5 (B-Cell Surface Antigen CD40 or CD40L Receptor or CD40) - Pipeline Review, H1 2016


    2016-06-15
    Global Markets Direct’s, ‘Tumor Necrosis Factor Receptor Superfamily Member 5 (B-Cell Surface Antigen CD40 or CD40L Receptor or CD40) - Pipeline Review, H1 2016’, provides in depth analysis on Tumor Necrosis Factor Receptor Superfamily...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0055TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0055TDB
  • View Report: Research and Experts Market Report: Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2016

    Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2016


    2016-06-15
    Global Markets Direct’s, ‘Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2016’, provides an overview of the Multiple Myeloma (Kahler Disease) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8160IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8160IDB
  • View Report: Research and Experts Market Report: Colon Cancer - Pipeline Review, H1 2016

    Colon Cancer - Pipeline Review, H1 2016


    2016-06-15
    Global Markets Direct’s, ‘Colon Cancer - Pipeline Review, H1 2016’, provides an overview of the Colon Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Colon Cancer, complete...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7965IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7965IDB
  • View Report: Research and Experts Market Report: Neuroendocrine Tumors - Pipeline Review, H1 2016

    Neuroendocrine Tumors - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Neuroendocrine Tumors - Pipeline Review, H1 2016’, provides an overview of the Neuroendocrine Tumors pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8174IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8174IDB
  • View Report: Research and Experts Market Report: Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2016

    Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2016’, provides an overview of the Bile Duct Cancer (Cholangiocarcinoma) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8167IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8167IDB
  • View Report: Research and Experts Market Report: Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2016

    Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2016


    2016-06-08
    Global Markets Direct’s, ‘Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2016’, provides an overview of the Kidney Cancer (Renal Cell Cancer) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8161IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8161IDB
  • View Report: Research and Experts Market Report: Age Related Macular Degeneration - Pipeline Review, H1 2016

    Age Related Macular Degeneration - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Age Related Macular Degeneration - Pipeline Review, H1 2016’, provides an overview of the Age Related Macular Degeneration pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7973IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7973IDB
  • View Report: Research and Experts Market Report: Metastatic Breast Cancer - Pipeline Review, H1 2016

    Metastatic Breast Cancer - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Metastatic Breast Cancer - Pipeline Review, H1 2016’, provides an overview of the Metastatic Breast Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7968IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7968IDB
  • View Report: Research and Experts Market Report: Type 1 diabetes (Juvenile Diabetes) - Pipeline Review, H1 2016

    Type 1 diabetes (Juvenile Diabetes) - Pipeline Review, H1 2016


    2016-06-08
    Global Markets Direct’s, ‘Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2016’, provides an overview of the Type 1 Diabetes (Juvenile Diabetes) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7967IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7967IDB
  • View Report: Research and Experts Market Report: Meningioma - Pipeline Review, H1 2016

    Meningioma - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Meningioma - Pipeline Review, H1 2016’, provides an overview of the Meningioma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Meningioma, complete...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8117IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC8117IDB
  • View Report: Research and Experts Market Report: Schizophrenia - Pipeline Review, H1 2016

    Schizophrenia - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Schizophrenia - Pipeline Review, H1 2016’, provides an overview of the Schizophrenia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Schizophrenia,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8107IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8107IDB
  • View Report: Research and Experts Market Report: Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016

    Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016’, provides an overview of the Chronic Lymphocytic Leukemia (CLL) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7977IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7977IDB
  • View Report: Research and Experts Market Report: Hepatocellular Carcinoma - Pipeline Review, H1 2016

    Hepatocellular Carcinoma - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Hepatocellular Carcinoma - Pipeline Review, H1 2016’, provides an overview of the Hepatocellular Carcinoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7971IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7971IDB
  • View Report: Research and Experts Market Report: Non-Hodgkin Lymphoma - Pipeline Review, H1 2016

    Non-Hodgkin Lymphoma - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Non-Hodgkin Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Non-Hodgkin Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Non-Hodgkin...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7970IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7970IDB
  • View Report: Research and Experts Market Report: Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016

    Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016’, provides an overview of the Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent)...
  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8003IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8003IDB
  • View Report: Research and Experts Market Report: Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2016

    Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2016’, provides an overview of the Refractory Acute Myeloid Leukemia pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8002IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8002IDB
  • View Report: Research and Experts Market Report: Epithelial Ovarian Cancer - Pipeline Review, H1 2016

    Epithelial Ovarian Cancer - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Epithelial Ovarian Cancer - Pipeline Review, H1 2016’, provides an overview of the Epithelial Ovarian Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8000IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8000IDB
  • View Report: Research and Experts Market Report: Follicular Lymphoma - Pipeline Review, H1 2016

    Follicular Lymphoma - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Follicular Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Follicular Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Follicular...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7999IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7999IDB
  • View Report: Research and Experts Market Report: Small-Cell Lung Cancer - Pipeline Review, H1 2016

    Small-Cell Lung Cancer - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Small-Cell Lung Cancer - Pipeline Review, H1 2016’, provides an overview of the Small-Cell Lung Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7991IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7991IDB
  • View Report: Research and Experts Market Report: Metastatic Colorectal Cancer - Pipeline Review, H1 2016

    Metastatic Colorectal Cancer - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Metastatic Colorectal Cancer - Pipeline Review, H1 2016’, provides an overview of the Metastatic Colorectal Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7985IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7985IDB
  • View Report: Research and Experts Market Report: Myelodysplastic Syndrome - Pipeline Review, H1 2016

    Myelodysplastic Syndrome - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Myelodysplastic Syndrome - Pipeline Review, H1 2016’, provides an overview of the Myelodysplastic Syndrome pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7984IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7984IDB
  • View Report: Research and Experts Market Report: Somatostatin Receptor Type 2 (SRIF-1 or SSTR2) - Pipeline Review, H1 2016

    Somatostatin Receptor Type 2 (SRIF-1 or SSTR2) - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Somatostatin Receptor Type 2 (SRIF-1 or SSTR2) - Pipeline Review, H1 2016’, provides in depth analysis on Somatostatin Receptor Type 2 (SRIF-1 or SSTR2) targeted pipeline therapeutics.

    The report provides comprehensive...

  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0034TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0034TDB
  • View Report: Research and Experts Market Report: Malignant Pleural Mesothelioma - Pipeline Review, H1 2016

    Malignant Pleural Mesothelioma - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Malignant Pleural Mesothelioma - Pipeline Review, H1 2016’, provides an overview of the Malignant Pleural Mesothelioma pipeline landscape.

    The report provides comprehensive information on the therapeutics under...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8025IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8025IDB
  • View Report: Research and Experts Market Report: Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H1 2016

    Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H1 2016’, provides an overview of the Adenocarcinoma Of The Gastroesophageal Junction pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8024IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8024IDB
  • View Report: Research and Experts Market Report: Thrombocytopenia - Pipeline Review, H1 2016

    Thrombocytopenia - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Thrombocytopenia - Pipeline Review, H1 2016’, provides an overview of the Thrombocytopenia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Thrombocytopenia,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8023IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8023IDB
  • View Report: Research and Experts Market Report: Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016

    Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016’, provides an overview of the Refractory Chronic Lymphocytic Leukemia (CLL) pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8019IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8019IDB
  • View Report: Research and Experts Market Report: Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016

    Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016’, provides an overview of the Relapsed Chronic Lymphocytic Leukemia (CLL) pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8017IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8017IDB
  • View Report: Research and Experts Market Report: Endometrial Cancer - Pipeline Review, H1 2016

    Endometrial Cancer - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Endometrial Cancer - Pipeline Review, H1 2016’, provides an overview of the Endometrial Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Endometrial...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8014IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8014IDB
  • View Report: Research and Experts Market Report: Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2016

    Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Diffuse Large B-Cell Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7986IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7986IDB
  • View Report: Research and Experts Market Report: Renal Cell Carcinoma - Pipeline Review, H1 2016

    Renal Cell Carcinoma - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Renal Cell Carcinoma - Pipeline Review, H1 2016’, provides an overview of the Renal Cell Carcinoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Renal...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7981IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7981IDB
  • View Report: Research and Experts Market Report: Melanin-Concentrating Hormone Receptor 1 (G-Protein Coupled Receptor 24 or MCH-1R or Somatostatin Receptor-Like Protein or MCHR1...

    Melanin-Concentrating Hormone Receptor 1 (G-Protein Coupled Receptor 24 or MCH-1R or Somatostatin Receptor-Like Protein or MCHR1 or GPR24 or SLC1) - Pipeline Review, H1 2016


    2016-05-11
    Global Markets Direct’s, ‘Melanin-Concentrating Hormone Receptor 1 (G-Protein Coupled Receptor 24 or MCH-1R or Somatostatin Receptor-Like Protein or MCHR1 or GPR24 or SLC1) - Pipeline Review, H1 2016’, provides in depth analysis on Melanin-Concentrating...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0024TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0024TDB
  • View Report: Research and Experts Market Report: Anaplastic Astrocytoma - Pipeline Review, H1 2016

    Anaplastic Astrocytoma - Pipeline Review, H1 2016


    2016-05-11
    Global Markets Direct’s, ‘Anaplastic Astrocytoma - Pipeline Review, H1 2016’, provides an overview of the Anaplastic Astrocytoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8041IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC8041IDB
  • View Report: Research and Experts Market Report: Ankylosing Spondylitis (Bekhterev

    Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H1 2016


    2016-05-11
    Global Markets Direct’s, ‘Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H1 2016’, provides an overview of the Ankylosing Spondylitis (Bekhterev's Disease) pipeline landscape.

    The report provides comprehensive...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8015IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8015IDB
  • View Report: Research and Experts Market Report: Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2016

    Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2016


    2016-05-11
    Global Markets Direct’s, ‘Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2016’, provides an overview of the Head And Neck Cancer Squamous Cell Carcinoma pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7988IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7988IDB
  • View Report: Research and Experts Market Report: B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2016

    B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2016


    2016-04-30
    Global Markets Direct’s, ‘B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2016’, provides an overview of the B-Cell Non-Hodgkin Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7687IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7687IDB
  • View Report: Research and Experts Market Report: Bradykinin B1 Receptor (B1R) - Pipeline Review, H1 2016

    Bradykinin B1 Receptor (B1R) - Pipeline Review, H1 2016


    2016-04-30
    Global Markets Direct’s, ‘Bradykinin B1 Receptor (B1R) - Pipeline Review, H1 2016’, provides in depth analysis on Bradykinin B1 Receptor (B1R) targeted pipeline therapeutics.

    The report provides comprehensive information on the Bradykinin...

  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0021TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0021TDB
  • View Report: Research and Experts Market Report: Calcitonin Gene Related Peptide (CGRP) - Pipeline Review, H1 2016

    Calcitonin Gene Related Peptide (CGRP) - Pipeline Review, H1 2016


    2016-04-30
    Global Markets Direct’s, ‘Calcitonin Gene Related Peptide (CGRP) - Pipeline Review, H1 2016’, provides in depth analysis on Calcitonin Gene Related Peptide (CGRP) targeted pipeline therapeutics.

    The report provides comprehensive information...

  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0013TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0013TDB
  • View Report: Research and Experts Market Report: Bladder Cancer - Pipeline Review, H1 2016

    Bladder Cancer - Pipeline Review, H1 2016


    2016-04-30
    Global Markets Direct’s, ‘Bladder Cancer - Pipeline Review, H1 2016’, provides an overview of the Bladder Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Bladder Cancer,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7982IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7982IDB
  • View Report: Research and Experts Market Report: Obesity - Pipeline Review, H1 2016

    Obesity - Pipeline Review, H1 2016


    2016-04-30
    Global Markets Direct’s, ‘Obesity - Pipeline Review, H1 2016’, provides an overview of the Obesity pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Obesity, complete with analysis...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7684IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7684IDB
  • View Report: Research and Experts Market Report: Dementia Associated With Alzheimer

    Dementia Associated With Alzheimer's Disease - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Dementia Associated With Alzheimer's Disease - Pipeline Review, H1 2016’, provides an overview of the Dementia Associated With Alzheimer's Disease pipeline landscape.

    The report provides comprehensive...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7887IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC7887IDB
  • View Report: Research and Experts Market Report: Osteoarthritis Pain - Pipeline Review, H1 2016

    Osteoarthritis Pain - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Osteoarthritis Pain - Pipeline Review, H1 2016’, provides an overview of the Osteoarthritis Pain pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Osteoarthritis...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7825IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7825IDB
  • View Report: Research and Experts Market Report: Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2016

    Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2016’, provides an overview of the Relapsed Acute Myeloid Leukemia pipeline landscape.

    The report provides comprehensive information on the therapeutics under...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7820IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7820IDB
  • View Report: Research and Experts Market Report: Fallopian Tube Cancer - Pipeline Review, H1 2016

    Fallopian Tube Cancer - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Fallopian Tube Cancer - Pipeline Review, H1 2016’, provides an overview of the Fallopian Tube Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7816IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7816IDB
  • View Report: Research and Experts Market Report: Gastric Cancer - Pipeline Review, H1 2016

    Gastric Cancer - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Gastric Cancer - Pipeline Review, H1 2016’, provides an overview of the Gastric Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Gastric Cancer,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7815IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7815IDB
  • View Report: Research and Experts Market Report: Head and neck Cancer - Pipeline Review, H1 2016

    Head and neck Cancer - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Head And Neck Cancer - Pipeline Review, H1 2016’, provides an overview of the Head And Neck Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Head...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7685IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7685IDB
  • View Report: Research and Experts Market Report: Asthma - Pipeline Review, H1 2016

    Asthma - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Asthma - Pipeline Review, H1 2016’, provides an overview of the Asthma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Asthma, complete with analysis...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7683IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7683IDB
  • View Report: Research and Experts Market Report: Type 2 Diabetes - Pipeline Review, H1 2016

    Type 2 Diabetes - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Type 2 Diabetes - Pipeline Review, H1 2016’, provides an overview of the Type 2 Diabetes pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Type 2 Diabetes,...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7682IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7682IDB
  • View Report: Research and Experts Market Report: Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016

    Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2016’, provides an overview of the Recurrent Glioblastoma Multiforme (GBM) pipeline landscape.

    The report provides comprehensive information on the...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7822IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7822IDB
  • View Report: Research and Experts Market Report: Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2016

    Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H1 2016’, provides an overview of the Plaque Psoriasis (Psoriasis Vulgaris) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7817IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7817IDB
  • View Report: Research and Experts Market Report: Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2016

    Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2016’, provides an overview of the Chronic Obstructive Pulmonary Disease (COPD) pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7688IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7688IDB
  • View Report: Research and Experts Market Report: Hepatitis C - Pipeline Review, H1 2016

    Hepatitis C - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Hepatitis C - Pipeline Review, H1 2016’, provides an overview of the Hepatitis C pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Hepatitis C, complete...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7638IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7638IDB
  • View Report: Research and Experts Market Report: Bronchitis - Pipeline Review, H1 2016

    Bronchitis - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Bronchitis - Pipeline Review, H1 2016’, provides an overview of the Bronchitis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Bronchitis, complete...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7903IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC7903IDB
  • View Report: Research and Experts Market Report: Rhabdomyosarcoma - Pipeline Review, H1 2016

    Rhabdomyosarcoma - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Rhabdomyosarcoma - Pipeline Review, H1 2016’, provides an overview of the Rhabdomyosarcoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Rhabdomyosarcoma,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7900IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7900IDB
  • View Report: Research and Experts Market Report: Oligodendroglioma - Pipeline Review, H1 2016

    Oligodendroglioma - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Oligodendroglioma - Pipeline Review, H1 2016’, provides an overview of the Oligodendroglioma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Oligodendroglioma,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7861IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7861IDB
  • View Report: Research and Experts Market Report: Lupus Nephritis - Pipeline Review, H1 2016

    Lupus Nephritis - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Lupus Nephritis - Pipeline Review, H1 2016’, provides an overview of the Lupus Nephritis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Lupus Nephritis,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7856IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7856IDB
  • View Report: Research and Experts Market Report: Cystic Fibrosis - Pipeline Review, H1 2016

    Cystic Fibrosis - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Cystic Fibrosis - Pipeline Review, H1 2016’, provides an overview of the Cystic Fibrosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Cystic Fibrosis,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7693IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7693IDB
  • View Report: Research and Experts Market Report: Metastatic Melanoma - Pipeline Review, H1 2016

    Metastatic Melanoma - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Metastatic Melanoma - Pipeline Review, H1 2016’, provides an overview of the Metastatic Melanoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Metastatic...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7691IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7691IDB
  • View Report: Research and Experts Market Report: Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016

    Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016’, provides an overview of the Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate...
  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7689IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7689IDB
  • View Report: Research and Experts Market Report: Psoriasis - Pipeline Review, H1 2016

    Psoriasis - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Psoriasis - Pipeline Review, H1 2016’, provides an overview of the Psoriasis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Psoriasis, complete with...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7686IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7686IDB
  • View Report: Research and Experts Market Report: Esophageal Cancer - Pipeline Review, H1 2016

    Esophageal Cancer - Pipeline Review, H1 2016


    2016-03-31
    Global Markets Direct’s, ‘Esophageal Cancer - Pipeline Review, H1 2016’, provides an overview of the Esophageal Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Esophageal...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7704IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7704IDB
  • View Report: Research and Experts Market Report: Metastatic Pancreatic Cancer - Pipeline Review, H1 2016

    Metastatic Pancreatic Cancer - Pipeline Review, H1 2016


    2016-03-31
    Global Markets Direct’s, ‘Metastatic Pancreatic Cancer - Pipeline Review, H1 2016’, provides an overview of the Metastatic Pancreatic Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7699IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7699IDB
  • View Report: Research and Experts Market Report: Peritoneal Cancer - Pipeline Review, H1 2016

    Peritoneal Cancer - Pipeline Review, H1 2016


    2016-03-31
    Global Markets Direct’s, ‘Peritoneal Cancer - Pipeline Review, H1 2016’, provides an overview of the Peritoneal Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Peritoneal...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7697IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7697IDB
  • View Report: Research and Experts Market Report: Cognitive Impairment - Pipeline Review, H1 2016

    Cognitive Impairment - Pipeline Review, H1 2016


    2016-03-31
    Global Markets Direct’s, ‘Cognitive Impairment - Pipeline Review, H1 2016’, provides an overview of the Cognitive Impairment pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Cognitive...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7696IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7696IDB
  • View Report: Research and Experts Market Report: Depression - Pipeline Review, H1 2016

    Depression - Pipeline Review, H1 2016


    2016-03-31
    Global Markets Direct’s, ‘Depression - Pipeline Review, H1 2016’, provides an overview of the Depression pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Depression, complete...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7581IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7581IDB
  • View Report: Research and Experts Market Report: Anxiety Disorders - Pipeline Review, H1 2016

    Anxiety Disorders - Pipeline Review, H1 2016


    2016-03-30
    Global Markets Direct’s, ‘Anxiety Disorders - Pipeline Review, H1 2016’, provides an overview of the Anxiety Disorders pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Anxiety...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7698IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7698IDB
  • View Report: Research and Experts Industry Report: Boehringer Ingelheim GmbH - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

    Boehringer Ingelheim GmbH - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report


    2016-06-30
    Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive...
  • Industry Report
  • Pharmaceuticals
  • Germany
  • $350.00
  • Report 05IK-35F7A23D-55FF-45E9-8650-F4 has a star rating of 4.4 out of 5
  • Go to More information on Report 05IK-35F7A23D-55FF-45E9-8650-F4
  • View Report: Research and Experts Industry Report: Biotechnology in Germany

    Biotechnology in Germany


    2015-02-12
    Biotechnology in Germany industry profile provides top-line qualitative and quantitative summary information including: market size (value 2010-14, and forecast to 2019). The profile also contains descriptions of the leading players including key financia...
  • Industry Report
  • Biotechnology
  • Germany
  • $350.00
  • Report 05IK-OHEC3236 has a star rating of 3.5 out of 5
  • Go to More information on Report 05IK-OHEC3236
  • View Report: Research and Experts Industry Report: Biotechnology in Europe

    Biotechnology in Europe


    2015-02-12
    Biotechnology in Europe industry profile provides top-line qualitative and quantitative summary information including: market size (value 2010-14, and forecast to 2019). The profile also contains descriptions of the leading players including key financial...
  • Industry Report
  • Biotechnology
  • Europe
  • $350.00
  • Report 05IK-OHEC3234 has a star rating of 3.3 out of 5
  • Go to More information on Report 05IK-OHEC3234
  • View Report: Research and Experts Industry Report: Biotechnology in Europe

    Biotechnology in Europe


    2016-01-18
    Biotechnology in Europe industry profile provides top-line qualitative and quantitative summary information including: market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial...
  • Industry Report
  • Biotechnology
  • Europe
  • $350.00
  • Report 05IK-OHME5117 has a star rating of 4.1 out of 5
  • Go to More information on Report 05IK-OHME5117
  • View Report: Research and Experts Industry Report: Biotechnology in Germany

    Biotechnology in Germany


    2016-01-18
    Biotechnology in Germany industry profile provides top-line qualitative and quantitative summary information including: market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financia...
  • Industry Report
  • Biotechnology
  • Germany
  • $350.00
  • Report 05IK-OHME4962 has a star rating of 4.2 out of 5
  • Go to More information on Report 05IK-OHME4962
  • View Report: Research and Experts Market Report: Rhinovirus Infection - Pipeline Review, H1 2016

    Rhinovirus Infection - Pipeline Review, H1 2016


    2016-03-22
    Global Markets Direct’s, ‘Rhinovirus Infection - Pipeline Review, H1 2016’, provides an overview of the Rhinovirus Infection pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Rhinovirus...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7745IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC7745IDB
  • View Report: Research and Experts Market Report: Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H1 2016

    Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H1 2016


    2016-03-22
    Global Markets Direct’s, ‘Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H1 2016’, provides an overview of the Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) pipeline landscape....
  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7732IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7732IDB
  • View Report: Research and Experts Market Report: Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H1 2016

    Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H1 2016


    2016-03-22
    Global Markets Direct’s, ‘Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H1 2016’, provides an overview of the Metastatic Adenocarcinoma of The Pancreas pipeline landscape.

    The report provides comprehensive information on...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7714IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7714IDB
  • View Report: Research and Experts Market Report: Medullary Thyroid Cancer - Pipeline Review, H1 2016

    Medullary Thyroid Cancer - Pipeline Review, H1 2016


    2016-03-16
    Global Markets Direct’s, ‘Medullary Thyroid Cancer - Pipeline Review, H1 2016’, provides an overview of the Medullary Thyroid Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7748IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7748IDB
  • View Report: Research and Experts Market Report: Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H1 2016

    Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H1 2016


    2016-03-16
    Global Markets Direct’s, ‘Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H1 2016’, provides an overview of the Wet (Neovascular / Exudative) Macular Degeneration pipeline landscape.

    The report provides comprehensive...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7702IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7702IDB
  • View Report: Research and Experts Market Report: Alzheimer

    Alzheimer's Disease - Pipeline Review, H1 2016


    2016-03-16
    Global Markets Direct’s, ‘Alzheimer’s Disease - Pipeline Review, H1 2016’, provides an overview of the Alzheimer’s Disease pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7570IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7570IDB
  • View Report: Research and Experts Market Report: Genital Herpes Global Clinical Trials Review, H1, 2016

    Genital Herpes Global Clinical Trials Review, H1, 2016


    2016-02-29
    GlobalData's clinical trial report, “Genital Herpes Global Clinical Trials Review, H1, 2016" provides an overview of Genital Herpes clinical trials scenario. This report provides top line data relating to the clinical trials on Genital...
  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IC-GDHC3246CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3246CTIDB
  • View Report: Research and Experts Company Report: Gilead Sciences, Inc. (GILD) - Medical Equipment - Deals and Alliances Profile

    Gilead Sciences, Inc. (GILD) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    Gilead Sciences, Inc. (Gilead) is a research-based biopharmaceutical company. It focuses on the discovery, development and commercialization of innovative medicines for diseases with unmet medical need. The company offers products in various therapeutic...
  • Company Report
  • Medical Devices
  • United States
  • $250.00
  • Report 05IB-GDME5315D has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GDME5315D
  • View Report: Research and Experts Company Report: AstraZeneca Plc (AZN) - Medical Equipment - Deals and Alliances Profile

    AstraZeneca Plc (AZN) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    AstraZeneca PLC (AstraZeneca) is a global biopharmaceutical company. It carries out design, development, production and commercialization of wide range of primary care and specialty care medicines. The company’s product portfolio includes biologics,...
  • Company Report
  • Medical Devices
  • United Kingdom
  • $250.00
  • Report 05IB-GDME3904D has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GDME3904D
  • View Report: Research and Experts Company Report: Sanofi (SAN) - Medical Equipment - Deals and Alliances Profile

    Sanofi (SAN) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    Sanofi is a healthcare company, which focuses on the research, development, manufacture and marketing of therapeutic solutions.The company offers a wide range of medicines, vaccines and innovative therapeutic solutions. Its product portfolio includes...
  • Company Report
  • Medical Devices
  • France
  • $250.00
  • Report 05IB-GDME3811D has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GDME3811D
  • View Report: Research and Experts Company Report: Abbott Laboratories (ABT) - Medical Equipment - Deals and Alliances Profile

    Abbott Laboratories (ABT) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    Abbott Laboratories (Abbott) is a healthcare company, which discovers, develops, manufactures, and sells a diversified range of healthcare products including drugs, diagnostics, branded generics, and vascular and nutritional products. The company’s...
  • Company Report
  • Medical Devices
  • United States
  • $250.00
  • Report 05IB-GDME1255D has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GDME1255D
  • View Report: Research and Experts Market Report: Indolent Lymphoma - Pipeline Review, H1 2016

    Indolent Lymphoma - Pipeline Review, H1 2016


    2016-02-29
    Global Markets Direct’s, ‘Indolent Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Indolent Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Indolent...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7663IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7663IDB
  • View Report: Research and Experts Market Report: Systemic Sclerosis (Scleroderma) - Pipeline Review, H1 2016

    Systemic Sclerosis (Scleroderma) - Pipeline Review, H1 2016


    2016-02-29
    Global Markets Direct’s, ‘Systemic Sclerosis (Scleroderma) - Pipeline Review, H1 2016’, provides an overview of the Systemic Sclerosis (Scleroderma) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7619IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7619IDB
  • View Report: Research and Experts Market Report: Diabetic Neuropathic Pain - Pipeline Review, H1 2016

    Diabetic Neuropathic Pain - Pipeline Review, H1 2016


    2016-02-29
    Global Markets Direct’s, ‘Diabetic Neuropathic Pain - Pipeline Review, H1 2016’, provides an overview of the Diabetic Neuropathic Pain pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7576IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7576IDB
  • View Report: Research and Experts Market Report: Sepsis - Pipeline Review, H1 2016

    Sepsis - Pipeline Review, H1 2016


    2016-02-24
    Global Markets Direct’s, ‘Sepsis - Pipeline Review, H1 2016’, provides an overview of the Sepsis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Sepsis, complete with analysis...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7672IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7672IDB
  • View Report: Research and Experts Market Report: Post-Operative Pain - Pipeline Review, H1 2016

    Post-Operative Pain - Pipeline Review, H1 2016


    2016-02-24
    Global Markets Direct’s, ‘Post-Operative Pain - Pipeline Review, H1 2016’, provides an overview of the Post-Operative Pain pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Post-Operative...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7548IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7548IDB
  • View Report: Research and Experts Market Report: Consumer and Market Insights: Suncare in Ireland

    Consumer and Market Insights: Suncare in Ireland


    2016-02-29
    Strong economic growth supported by recovering investments in Ireland will create new opportunities for producers in the overall consumer goods market. Suncare market in Ireland will register higher growth during 2015-2020 compared to 2010-2015. Sun Prote...
  • Market Report
  • Iron and steel Construction
  • Ireland
  • $875.00
  • Report 01GZ-CS2841MF has a star rating of 4.4 out of 5
  • Go to More information on Report 01GZ-CS2841MF
  • View Report: Research and Experts Market Report: Chronic Stable Angina Global Clinical Trials Review, H1, 2016

    Chronic Stable Angina Global Clinical Trials Review, H1, 2016


    2016-01-31
    GlobalData's clinical trial report, “Chronic Stable Angina Global Clinical Trials Review, H1, 2016" provides an overview of Chronic Stable Angina clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3203CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3203CTIDB
  • View Report: Research and Experts Market Report: Consumer and Market Insights: Personal Hygiene Market in Netherlands

    Consumer and Market Insights: Personal Hygiene Market in Netherlands


    2016-02-25
    Anti-Perspirants & Deodorants is the leading value category, accounting for a majority of the Personal Hygiene market in 2015 while the Soap category is forecast to register the highest CAGR of 4.6% during the same period. The Anti-Perspirants &...
  • Market Report
  • Cosmetics
  • Netherlands
  • $1,272.00
  • Report 01GZ-CS2547MF has a star rating of 4.6 out of 5
  • Go to More information on Report 01GZ-CS2547MF
  • View Report: Research and Experts Market Report: Osteoarthritis Pain - Pipeline Review, H2 2015

    Osteoarthritis Pain - Pipeline Review, H2 2015


    2015-10-30
    Osteoarthritis Pain - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Osteoarthritis Pain - Pipeline Review, H2 2015’, provides an overview of the Osteoarthritis Pain’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7221IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7221IDB
  • View Report: Research and Experts Market Report: Epithelial Ovarian Cancer - Pipeline Review, H2 2015

    Epithelial Ovarian Cancer - Pipeline Review, H2 2015


    2015-10-30
    Epithelial Ovarian Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Epithelial Ovarian Cancer - Pipeline Review, H2 2015’, provides an overview of the Epithelial Ovarian Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7214IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7214IDB
  • View Report: Research and Experts Market Report: Malignant Pleural Mesothelioma - Pipeline Review, H2 2015

    Malignant Pleural Mesothelioma - Pipeline Review, H2 2015


    2015-10-30
    Malignant Pleural Mesothelioma - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Malignant Pleural Mesothelioma - Pipeline Review, H2 2015’, provides an overview of the Malignant Pleural Mesothelioma’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7231IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7231IDB
  • View Report: Research and Experts Market Report: Adenocarcinoma of the Gastroesophageal Junction - Pipeline Review, H2 2015

    Adenocarcinoma of the Gastroesophageal Junction - Pipeline Review, H2 2015


    2015-10-30
    Adenocarcinoma of the Gastroesophageal Junction - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H2 2015’, provides an overview of the Adenocarcinoma Of The...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7228IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7228IDB
  • View Report: Research and Experts Market Report: Ankylosing Spondylitis (Bekhterev

    Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H2 2015


    2015-10-30
    Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H2 2015’, provides an overview of the Ankylosing Spondylitis...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7227IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7227IDB
  • View Report: Research and Experts Market Report: Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2015

    Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2015


    2015-10-30
    Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Refractory Acute Myeloid Leukemia - Pipeline Review, H2 2015’, provides an overview of the Refractory Acute Myeloid Leukemia’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7212IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7212IDB
  • View Report: Research and Experts Market Report: Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2015

    Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2015


    2015-10-30
    Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7211IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7211IDB
  • View Report: Research and Experts Market Report: Liver Fibrosis - Pipeline Review, H2 2015

    Liver Fibrosis - Pipeline Review, H2 2015


    2015-10-28
    Liver Fibrosis - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Liver Fibrosis - Pipeline Review, H2 2015’, provides an overview of the Liver Fibrosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7289IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7289IDB
  • View Report: Research and Experts Market Report: Post-Operative Pain - Pipeline Review, H2 2015

    Post-Operative Pain - Pipeline Review, H2 2015


    2015-10-28
    Post-Operative Pain - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Post-Operative Pain - Pipeline Review, H2 2015’, provides an overview of the Post-Operative Pain’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7286IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7286IDB
  • View Report: Research and Experts Market Report: Rhabdomyosarcoma - Pipeline Review, H2 2015

    Rhabdomyosarcoma - Pipeline Review, H2 2015


    2015-10-28
    Rhabdomyosarcoma - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Rhabdomyosarcoma - Pipeline Review, H2 2015’, provides an overview of the Rhabdomyosarcoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7267IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC7267IDB
  • View Report: Research and Experts Market Report: Esophageal Cancer - Pipeline Review, H2 2015

    Esophageal Cancer - Pipeline Review, H2 2015


    2015-10-21
    Esophageal Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Esophageal Cancer - Pipeline Review, H2 2015’, provides an overview of the Esophageal Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6962IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC6962IDB
  • View Report: Research and Experts Market Report: Non-Alcoholic Steatohepatitis - Pipeline Review, H2 2015

    Non-Alcoholic Steatohepatitis - Pipeline Review, H2 2015


    2015-10-21
    Non-Alcoholic Steatohepatitis - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Non-Alcoholic Steatohepatitis - Pipeline Review, H2 2015’, provides an overview of the Non-Alcoholic Steatohepatitis’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6840IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC6840IDB
  • View Report: Research and Experts Market Report: Brain Cancer - Pipeline Review, H2 2015

    Brain Cancer - Pipeline Review, H2 2015


    2015-10-21
    Brain Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Brain Cancer - Pipeline Review, H2 2015’, provides an overview of the Brain Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6838IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC6838IDB
  • View Report: Research and Experts Market Report: Diabetic Neuropathic Pain - Pipeline Review, H2 2015

    Diabetic Neuropathic Pain - Pipeline Review, H2 2015


    2015-10-14
    Diabetic Neuropathic Pain - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Diabetic Neuropathic Pain - Pipeline Review, H2 2015’, provides an overview of the Diabetic Neuropathic Pain’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6858IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6858IDB
  • View Report: Research and Experts Market Report: Refractory Multiple Myeloma - Pipeline Review, H2 2015

    Refractory Multiple Myeloma - Pipeline Review, H2 2015


    2015-09-30
    Refractory Multiple Myeloma - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Refractory Multiple Myeloma - Pipeline Review, H2 2015’, provides an overview of the Refractory Multiple Myeloma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7074IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7074IDB
  • View Report: Research and Experts Market Report: Cognitive Impairment - Pipeline Review, H2 2015

    Cognitive Impairment - Pipeline Review, H2 2015


    2015-09-30
    Cognitive Impairment - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Cognitive Impairment - Pipeline Review, H2 2015’, provides an overview of the Cognitive Impairment’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7070IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7070IDB
  • View Report: Research and Experts Market Report: Oligodendroglioma - Pipeline Review, H2 2015

    Oligodendroglioma - Pipeline Review, H2 2015


    2015-09-30
    Oligodendroglioma - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Oligodendroglioma - Pipeline Review, H2 2015’, provides an overview of the Oligodendroglioma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7173IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC7173IDB
  • View Report: Research and Experts Market Report: Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H2 2015

    Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H2 2015


    2015-09-30
    Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H2 2015’, provides an overview of the Metastatic Adenocarcinoma of The...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6979IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6979IDB
  • View Report: Research and Experts Market Report: Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2015

    Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2015


    2015-09-23
    Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2015’, provides an overview of the Recurrent Glioblastoma Multiforme (GBM)’s...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7083IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7083IDB
  • View Report: Research and Experts Market Report: Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2015

    Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2015


    2015-09-23
    Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Relapsed Acute Myeloid Leukemia - Pipeline Review, H2 2015’, provides an overview of the Relapsed Acute Myeloid Leukemia’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7077IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7077IDB
  • View Report: Research and Experts Market Report: Fallopian Tube Cancer - Pipeline Review, H2 2015

    Fallopian Tube Cancer - Pipeline Review, H2 2015


    2015-09-23
    Fallopian Tube Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Fallopian Tube Cancer - Pipeline Review, H2 2015’, provides an overview of the Fallopian Tube Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7075IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7075IDB
  • View Report: Research and Experts Market Report: Medullary Thyroid Cancer - Pipeline Review, H2 2015

    Medullary Thyroid Cancer - Pipeline Review, H2 2015


    2015-09-16
    Medullary Thyroid Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Medullary Thyroid Cancer - Pipeline Review, H2 2015’, provides an overview of the Medullary Thyroid Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7126IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC7126IDB
  • View Report: Research and Experts Market Report: Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H2 2015

    Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H2 2015


    2015-09-16
    Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H2 2015’, provides an overview of the Transitional Cell...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7098IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7098IDB
  • View Report: Research and Experts Market Report: Mild Cognitive Impairment - Pipeline Review, H2 2015

    Mild Cognitive Impairment - Pipeline Review, H2 2015


    2015-08-31
    Mild Cognitive Impairment - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Mild cognitive impairment - Pipeline Review, H2 2015’, provides an overview of the Mild cognitive impairment’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7058IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC7058IDB
  • View Report: Research and Experts Market Report: Indolent Lymphoma - Pipeline Review, H2 2015

    Indolent Lymphoma - Pipeline Review, H2 2015


    2015-08-31
    Indolent Lymphoma - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Indolent Lymphoma - Pipeline Review, H2 2015’, provides an overview of the Indolent Lymphoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6983IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6983IDB
  • View Report: Research and Experts Market Report: Squamous Non-Small Cell Lung Cancer - Pipeline Review, H2 2015

    Squamous Non-Small Cell Lung Cancer - Pipeline Review, H2 2015


    2015-08-31
    Squamous Non-Small Cell Lung Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Squamous Non-Small Cell Lung Cancer - Pipeline Review, H2 2015’, provides an overview of the Squamous Non-Small Cell Lung Cancer’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6982IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6982IDB
  • View Report: Research and Experts Market Report: Gastric Cancer - Pipeline Review, H2 2015

    Gastric Cancer - Pipeline Review, H2 2015


    2015-08-26
    Gastric Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Gastric Cancer - Pipeline Review, H2 2015’, provides an overview of the Gastric Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7055IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7055IDB
  • View Report: Research and Experts Market Report: Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2015

    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2015


    2015-08-19
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2015’, provides an overview of...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7054IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7054IDB
  • View Report: Research and Experts Market Report: Rhinovirus Infection - Pipeline Review, H2 2015

    Rhinovirus Infection - Pipeline Review, H2 2015


    2015-08-19
    Rhinovirus Infection - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Rhinovirus Infection - Pipeline Review, H2 2015’, provides an overview of the Rhinovirus Infection’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7007IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC7007IDB
  • View Report: Research and Experts Market Report: Chronic Bronchitis - Pipeline Review, H2 2015

    Chronic Bronchitis - Pipeline Review, H2 2015


    2015-08-12
    Chronic Bronchitis - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Chronic Bronchitis - Pipeline Review, H2 2015’, provides an overview of the Chronic Bronchitis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7036IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC7036IDB
  • View Report: Research and Experts Market Report: Chronic Plaque Psoriasis - Pipeline Review, H2 2015

    Chronic Plaque Psoriasis - Pipeline Review, H2 2015


    2015-07-31
    Chronic Plaque Psoriasis - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Chronic Plaque Psoriasis - Pipeline Review, H2 2015’, provides an overview of the Chronic Plaque Psoriasis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6862IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6862IDB
  • View Report: Research and Experts Market Report: Metastatic Breast Cancer - Pipeline Review, H1 2015

    Metastatic Breast Cancer - Pipeline Review, H1 2015


    2015-06-30
    Metastatic Breast Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Breast Cancer - Pipeline Review, H1 2015’, provides an overview of the Metastatic Breast Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6507IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6507IDB
  • View Report: Research and Experts Market Report: Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015

    Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015


    2015-06-30
    Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015’, provides an overview of the Glioblastoma Multiforme (GBM)’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6676IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6676IDB
  • View Report: Research and Experts Market Report: Ovarian Cancer - Pipeline Review, H1 2015

    Ovarian Cancer - Pipeline Review, H1 2015


    2015-06-30
    Ovarian Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Ovarian Cancer - Pipeline Review, H1 2015’, provides an overview of the Ovarian Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6675IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6675IDB
  • View Report: Research and Experts Market Report: Pancreatic Cancer - Pipeline Review, H1 2015

    Pancreatic Cancer - Pipeline Review, H1 2015


    2015-06-30
    Pancreatic Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Pancreatic Cancer - Pipeline Review, H1 2015’, provides an overview of the Pancreatic Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6674IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6674IDB
  • View Report: Research and Experts Market Report: Liver Cancer - Pipeline Review, H1 2015

    Liver Cancer - Pipeline Review, H1 2015


    2015-06-30
    Liver Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Liver Cancer - Pipeline Review, H1 2015’, provides an overview of the Liver Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6563IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6563IDB
  • View Report: Research and Experts Market Report: Colorectal Cancer - Pipeline Review, H1 2015

    Colorectal Cancer - Pipeline Review, H1 2015


    2015-06-30
    Colorectal Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Colorectal Cancer - Pipeline Review, H1 2015’, provides an overview of the Colorectal Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6504IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6504IDB
  • View Report: Research and Experts Market Report: Melanoma - Pipeline Review, H1 2015

    Melanoma - Pipeline Review, H1 2015


    2015-06-30
    Melanoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Melanoma - Pipeline Review, H1 2015’, provides an overview of the Melanoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6503IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6503IDB
  • View Report: Research and Experts Market Report: Prostate Cancer - Pipeline Review, H1 2015

    Prostate Cancer - Pipeline Review, H1 2015


    2015-06-30
    Prostate Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Prostate Cancer - Pipeline Review, H1 2015’, provides an overview of the Prostate Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6502IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6502IDB
  • View Report: Research and Experts Market Report: Non-Hodgkin Lymphoma - Pipeline Review, H1 2015

    Non-Hodgkin Lymphoma - Pipeline Review, H1 2015


    2015-06-30
    Non-Hodgkin Lymphoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Non-Hodgkin Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Non-Hodgkin Lymphoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6498IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6498IDB
  • View Report: Research and Experts Market Report: Non-Small Cell Lung Cancer - Pipeline Review, H1 2015

    Non-Small Cell Lung Cancer - Pipeline Review, H1 2015


    2015-06-30
    Non-Small Cell Lung Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Non-Small Cell Lung Cancer - Pipeline Review, H1 2015’, provides an overview of the Non-Small Cell Lung Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6495IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6495IDB
  • View Report: Research and Experts Market Report: Metastatic Colorectal Cancer - Pipeline Review, H1 2015

    Metastatic Colorectal Cancer - Pipeline Review, H1 2015


    2015-06-30
    Metastatic Colorectal Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Colorectal Cancer - Pipeline Review, H1 2015’, provides an overview of the Metastatic Colorectal Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6570IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6570IDB
  • View Report: Research and Experts Market Report: Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015

    Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015


    2015-06-30
    Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015’, provides an overview of the Chronic Lymphocytic Leukemia (CLL)’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6567IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6567IDB
  • View Report: Research and Experts Market Report: Rheumatoid Arthritis - Pipeline Review, H1 2015

    Rheumatoid Arthritis - Pipeline Review, H1 2015


    2015-06-30
    Rheumatoid Arthritis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Rheumatoid Arthritis - Pipeline Review, H1 2015’, provides an overview of the Rheumatoid Arthritis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6561IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6561IDB
  • View Report: Research and Experts Market Report: Hepatocellular Carcinoma - Pipeline Review, H1 2015

    Hepatocellular Carcinoma - Pipeline Review, H1 2015


    2015-06-30
    Hepatocellular Carcinoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Hepatocellular Carcinoma - Pipeline Review, H1 2015’, provides an overview of the Hepatocellular Carcinoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6499IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6499IDB
  • View Report: Research and Experts Market Report: HIV / AIDS - Pipeline Review, H1 2015

    HIV / AIDS - Pipeline Review, H1 2015


    2015-06-30
    HIV / AIDS - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘HIV / AIDS - Pipeline Review, H1 2015’, provides an overview of the HIV / AIDS’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6496IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6496IDB
  • View Report: Research and Experts Market Report: Inflammatory Bowel Disease - Pipeline Review, H1 2015

    Inflammatory Bowel Disease - Pipeline Review, H1 2015


    2015-06-30
    Inflammatory Bowel Disease - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Inflammatory Bowel Disease - Pipeline Review, H1 2015’, provides an overview of the Inflammatory Bowel Disease’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6494IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6494IDB
  • View Report: Research and Experts Market Report: Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H1 2015

    Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H1 2015


    2015-06-30
    Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H1 2015’, provides an overview of the Transitional...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6814IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6814IDB
  • View Report: Research and Experts Market Report: Age Related Macular Degeneration - Pipeline Review, H1 2015

    Age Related Macular Degeneration - Pipeline Review, H1 2015


    2015-06-30
    Age Related Macular Degeneration - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Age Related Macular Degeneration - Pipeline Review, H1 2015’, provides an overview of the Age Related Macular Degeneration’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6679IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6679IDB
  • View Report: Research and Experts Market Report: Crohn

    Crohn's Disease - Pipeline Review, H1 2015


    2015-06-30
    Crohn's Disease - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Crohn's Disease - Pipeline Review, H1 2015’, provides an overview of the Crohn's Disease’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6569IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6569IDB
  • View Report: Research and Experts Market Report: Schizophrenia - Pipeline Review, H1 2015

    Schizophrenia - Pipeline Review, H1 2015


    2015-06-30
    Schizophrenia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Schizophrenia - Pipeline Review, H1 2015’, provides an overview of the Schizophrenia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6568IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6568IDB
  • View Report: Research and Experts Market Report: Kidney Cancer - Pipeline Review, H1 2015

    Kidney Cancer - Pipeline Review, H1 2015


    2015-06-30
    Kidney Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Kidney Cancer - Pipeline Review, H1 2015’, provides an overview of the Kidney Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6492IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6492IDB
  • View Report: Research and Experts Market Report: Neuropathic Pain - Pipeline Review, H1 2015

    Neuropathic Pain - Pipeline Review, H1 2015


    2015-06-30
    Neuropathic Pain - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Neuropathic Pain - Pipeline Review, H1 2015’, provides an overview of the Neuropathic Pain’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6491IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6491IDB
  • View Report: Research and Experts Market Report: Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2015

    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2015


    2015-06-30
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2015’, provides an overview of...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6490IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6490IDB
  • View Report: Research and Experts Market Report: Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2015

    Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2015


    2015-06-30
    Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2015’, provides an overview of the Head And Neck Cancer Squamous...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6515IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6515IDB
  • View Report: Research and Experts Market Report: Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2015

    Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2015


    2015-06-30
    Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Refractory Acute Myeloid Leukemia - Pipeline Review, H1 2015’, provides an overview of the Refractory Acute Myeloid Leukemia’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6519IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6519IDB
  • View Report: Research and Experts Market Report: Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2015

    Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2015


    2015-06-30
    Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6518IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6518IDB
  • View Report: Research and Experts Market Report: Thrombocytopenia - Pipeline Review, H1 2015

    Thrombocytopenia - Pipeline Review, H1 2015


    2015-06-24
    Thrombocytopenia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Thrombocytopenia - Pipeline Review, H1 2015’, provides an overview of the Thrombocytopenia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6698IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6698IDB
  • View Report: Research and Experts Market Report: Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015

    Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015


    2015-06-24
    Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015’, provides an overview of the Refractory Chronic Lymphocytic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6697IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6697IDB
  • View Report: Research and Experts Market Report: Follicular Lymphoma - Pipeline Review, H1 2015

    Follicular Lymphoma - Pipeline Review, H1 2015


    2015-06-24
    Follicular Lymphoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Follicular Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Follicular Lymphoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6690IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6690IDB
  • View Report: Research and Experts Market Report: Small-Cell Lung Cancer - Pipeline Review, H1 2015

    Small-Cell Lung Cancer - Pipeline Review, H1 2015


    2015-06-24
    Small-Cell Lung Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Small-Cell Lung Cancer - Pipeline Review, H1 2015’, provides an overview of the Small-Cell Lung Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6686IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6686IDB
  • View Report: Research and Experts Market Report: Myelodysplastic Syndrome - Pipeline Review, H1 2015

    Myelodysplastic Syndrome - Pipeline Review, H1 2015


    2015-06-24
    Myelodysplastic Syndrome - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Myelodysplastic Syndrome - Pipeline Review, H1 2015’, provides an overview of the Myelodysplastic Syndrome’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6685IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6685IDB
  • View Report: Research and Experts Market Report: Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2015

    Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2015


    2015-06-24
    Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Diffuse Large B-Cell Lymphoma’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6684IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6684IDB
  • View Report: Research and Experts Market Report: Renal Cell Carcinoma - Pipeline Review, H1 2015

    Renal Cell Carcinoma - Pipeline Review, H1 2015


    2015-06-24
    Renal Cell Carcinoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Renal Cell Carcinoma - Pipeline Review, H1 2015’, provides an overview of the Renal Cell Carcinoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6681IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6681IDB
  • View Report: Research and Experts Market Report: Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015

    Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015


    2015-06-17
    Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015’, provides an overview of the Relapsed Chronic Lymphocytic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6699IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6699IDB
  • View Report: Research and Experts Market Report: Endometrial Cancer - Pipeline Review, H1 2015

    Endometrial Cancer - Pipeline Review, H1 2015


    2015-05-29
    Endometrial Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Endometrial Cancer - Pipeline Review, H1 2015’, provides an overview of the Endometrial Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6584IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6584IDB
  • View Report: Research and Experts Market Report: Malignant Mesothelioma - Pipeline Review, H1 2015

    Malignant Mesothelioma - Pipeline Review, H1 2015


    2015-05-29
    Malignant Mesothelioma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Malignant Mesothelioma - Pipeline Review, H1 2015’, provides an overview of the Malignant Mesothelioma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6582IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6582IDB
  • View Report: Research and Experts Market Report: Soft Tissue Sarcoma - Pipeline Review, H1 2015

    Soft Tissue Sarcoma - Pipeline Review, H1 2015


    2015-05-29
    Soft Tissue Sarcoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Soft Tissue Sarcoma - Pipeline Review, H1 2015’, provides an overview of the Soft Tissue Sarcoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6580IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6580IDB
  • View Report: Research and Experts Market Report: Epithelial Ovarian Cancer - Pipeline Review, H1 2015

    Epithelial Ovarian Cancer - Pipeline Review, H1 2015


    2015-05-29
    Epithelial Ovarian Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Epithelial Ovarian Cancer - Pipeline Review, H1 2015’, provides an overview of the Epithelial Ovarian Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6521IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6521IDB
  • View Report: Research and Experts Market Report: High-Grade Glioma - Pipeline Review, H1 2015

    High-Grade Glioma - Pipeline Review, H1 2015


    2015-05-29
    High-Grade Glioma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘High-Grade Glioma - Pipeline Review, H1 2015’, provides an overview of the High-Grade Glioma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6725IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6725IDB
  • View Report: Research and Experts Market Report: Lung Adenocarcinoma - Pipeline Review, H1 2015

    Lung Adenocarcinoma - Pipeline Review, H1 2015


    2015-05-29
    Lung Adenocarcinoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Lung Adenocarcinoma - Pipeline Review, H1 2015’, provides an overview of the Lung Adenocarcinoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6718IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6718IDB
  • View Report: Research and Experts Market Report: Malignant Pleural Mesothelioma - Pipeline Review, H1 2015

    Malignant Pleural Mesothelioma - Pipeline Review, H1 2015


    2015-05-29
    Malignant Pleural Mesothelioma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Malignant Pleural Mesothelioma - Pipeline Review, H1 2015’, provides an overview of the Malignant Pleural Mesothelioma’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6536IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6536IDB
  • View Report: Research and Experts Market Report: Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H1 2015

    Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H1 2015


    2015-05-29
    Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H1 2015’, provides an overview of the Adenocarcinoma Of The...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6533IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6533IDB
  • View Report: Research and Experts Market Report: Ankylosing Spondylitis (Bekhterev

    Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H1 2015


    2015-05-29
    Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Ankylosing Spondylitis (Bekhterev's Disease) - Pipeline Review, H1 2015’, provides an overview of the Ankylosing Spondylitis...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6532IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6532IDB
  • View Report: Research and Experts Market Report: Osteoarthritis Pain - Pipeline Review, H1 2015

    Osteoarthritis Pain - Pipeline Review, H1 2015


    2015-05-29
    Osteoarthritis Pain - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Osteoarthritis Pain - Pipeline Review, H1 2015’, provides an overview of the Osteoarthritis Pain’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6526IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6526IDB
  • View Report: Research and Experts Market Report: Nephropathy - Pipeline Review, H1 2015

    Nephropathy - Pipeline Review, H1 2015


    2015-05-20
    Nephropathy - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Nephropathy - Pipeline Review, H1 2015’, provides an overview of the Nephropathy’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6729IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6729IDB
  • View Report: Research and Experts Market Report: Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2015

    Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2015


    2015-05-13
    Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2015’, provides an overview of the Type 1 Diabetes (Juvenile Diabetes)’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6506IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6506IDB
  • View Report: Research and Experts Market Report: Anaplastic Astrocytoma - Pipeline Review, H1 2015

    Anaplastic Astrocytoma - Pipeline Review, H1 2015


    2015-05-13
    Anaplastic Astrocytoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Anaplastic Astrocytoma - Pipeline Review, H1 2015’, provides an overview of the Anaplastic Astrocytoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6750IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6750IDB
  • View Report: Research and Experts Market Report: Mild Cognitive Impairment - Pipeline Review, H1 2015

    Mild Cognitive Impairment - Pipeline Review, H1 2015


    2015-04-30
    Mild Cognitive Impairment - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Mild Cognitive Impairment - Pipeline Review, H1 2015’, provides an overview of the Mild Cognitive Impairment’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6544IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6544IDB
  • View Report: Research and Experts Market Report: Severe Psoriasis - Pipeline Review, H1 2015

    Severe Psoriasis - Pipeline Review, H1 2015


    2015-04-29
    Severe Psoriasis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Severe Psoriasis - Pipeline Review, H1 2015’, provides an overview of the Severe Psoriasis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6610IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6610IDB
  • View Report: Research and Experts Market Report: Moderate Psoriasis - Pipeline Review, H1 2015

    Moderate Psoriasis - Pipeline Review, H1 2015


    2015-04-29
    Moderate Psoriasis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Moderate Psoriasis - Pipeline Review, H1 2015’, provides an overview of the Moderate Psoriasis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6598IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6598IDB
  • View Report: Research and Experts Market Report: Cognitive Impairment - Pipeline Review, H1 2015

    Cognitive Impairment - Pipeline Review, H1 2015


    2015-03-31
    Cognitive Impairment - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Cognitive Impairment - Pipeline Review, H1 2015’, provides an overview of the Cognitive Impairment’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6243IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6243IDB
  • View Report: Research and Experts Market Report: HIV-1 Infection - Pipeline Review, H1 2015

    HIV-1 Infection - Pipeline Review, H1 2015


    2015-03-31
    HIV-1 Infection - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘HIV-1 Infection - Pipeline Review, H1 2015’, provides an overview of the HIV-1 Infection’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6239IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6239IDB
  • View Report: Research and Experts Market Report: Gastric Cancer - Pipeline Review, H1 2015

    Gastric Cancer - Pipeline Review, H1 2015


    2015-03-31
    Gastric Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Gastric Cancer - Pipeline Review, H1 2015’, provides an overview of the Gastric Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6238IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6238IDB
  • View Report: Research and Experts Market Report: Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2015

    Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2015


    2015-03-26
    Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2015’, provides an overview of the Idiopathic Pulmonary Fibrosis’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6473IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6473IDB
  • View Report: Research and Experts Market Report: Psoriasis - Pipeline Review, H1 2015

    Psoriasis - Pipeline Review, H1 2015


    2015-03-26
    Psoriasis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Psoriasis - Pipeline Review, H1 2015’, provides an overview of the Psoriasis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6361IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6361IDB
  • View Report: Research and Experts Market Report: Emphysema - Pipeline Review, H1 2015

    Emphysema - Pipeline Review, H1 2015


    2015-03-19
    Emphysema - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Emphysema - Pipeline Review, H1 2015’, provides an overview of the Emphysema’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6434IDB has a star rating of 3.5 out of 5
  • Go to More information on Report 05IB-GMDHC6434IDB
  • View Report: Research and Experts Market Report: Rhabdomyosarcoma - Pipeline Review, H1 2015

    Rhabdomyosarcoma - Pipeline Review, H1 2015


    2015-03-19
    Rhabdomyosarcoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Rhabdomyosarcoma - Pipeline Review, H1 2015’, provides an overview of the Rhabdomyosarcoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6429IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6429IDB
  • View Report: Research and Experts Market Report: Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2015

    Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2015


    2015-03-19
    Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Relapsed Acute Myeloid Leukemia - Pipeline Review, H1 2015’, provides an overview of the Relapsed Acute Myeloid Leukemia’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6250IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6250IDB
  • View Report: Research and Experts Market Report: Fallopian Tube Cancer - Pipeline Review, H1 2015

    Fallopian Tube Cancer - Pipeline Review, H1 2015


    2015-03-19
    Fallopian Tube Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Fallopian Tube Cancer - Pipeline Review, H1 2015’, provides an overview of the Fallopian Tube Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6248IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6248IDB
  • View Report: Research and Experts Market Report: Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H1 2015

    Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H1 2015


    2015-02-28
    Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H1 2015’, provides...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6354IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6354IDB
  • View Report: Research and Experts Market Report: Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015

    Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015


    2015-03-11
    Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Recurrent Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015’, provides an overview of the Recurrent Glioblastoma Multiforme (GBM)’s...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6256IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6256IDB
  • View Report: Research and Experts Market Report: Medullary Thyroid Cancer - Pipeline Review, H1 2015

    Medullary Thyroid Cancer - Pipeline Review, H1 2015


    2015-02-18
    Medullary Thyroid Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Medullary Thyroid Cancer - Pipeline Review, H1 2015’, provides an overview of the Medullary Thyroid Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6300IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6300IDB
  • View Report: Research and Experts Market Report: B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015

    B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015


    2015-02-18
    B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015’, provides an overview of the B-Cell Non-Hodgkin Lymphoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6127IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6127IDB
  • View Report: Research and Experts Market Report: Anxiety Disorders - Pipeline Review, H1 2015

    Anxiety Disorders - Pipeline Review, H1 2015


    2015-02-10
    Anxiety Disorders - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Anxiety Disorders - Pipeline Review, H1 2015’, provides an overview of the Anxiety Disorders’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6131IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6131IDB
  • View Report: Research and Experts Market Report: Type 2 Diabetes - Pipeline Review, H1 2015

    Type 2 Diabetes - Pipeline Review, H1 2015


    2015-02-10
    Type 2 Diabetes - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Type 2 Diabetes - Pipeline Review, H1 2015’, provides an overview of the Type 2 Diabetes’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6121IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6121IDB
  • View Report: Research and Experts Market Report: Chronic Bronchitis - Pipeline Review, H1 2015

    Chronic Bronchitis - Pipeline Review, H1 2015


    2015-01-30
    Chronic Bronchitis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Chronic Bronchitis - Pipeline Review, H1 2015’, provides an overview of the Chronic Bronchitis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6214IDB has a star rating of 3.2 out of 5
  • Go to More information on Report 05IB-GMDHC6214IDB
  • View Report: Research and Experts Market Report: Renal Insufficiency - Pipeline Review, H1 2015

    Renal Insufficiency - Pipeline Review, H1 2015


    2015-01-30
    Renal Insufficiency - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Renal Insufficiency - Pipeline Review, H1 2015’, provides an overview of the Renal Insufficiency’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6205IDB has a star rating of 3.2 out of 5
  • Go to More information on Report 05IB-GMDHC6205IDB
  • View Report: Research and Experts Market Report: Rhinovirus Infection - Pipeline Review, H1 2015

    Rhinovirus Infection - Pipeline Review, H1 2015


    2015-01-30
    Rhinovirus Infection - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Rhinovirus Infection - Pipeline Review, H1 2015’, provides an overview of the Rhinovirus Infection’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6185IDB has a star rating of 3.3 out of 5
  • Go to More information on Report 05IB-GMDHC6185IDB
  • View Report: Research and Experts Market Report: Esophageal Cancer - Pipeline Review, H1 2015

    Esophageal Cancer - Pipeline Review, H1 2015


    2015-01-30
    Esophageal Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Esophageal Cancer - Pipeline Review, H1 2015’, provides an overview of the Esophageal Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6140IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6140IDB
  • View Report: Research and Experts Market Report: Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2015

    Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2015


    2015-01-30
    Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Chronic Obstructive Pulmonary Disease (COPD) - Pipeline Review, H1 2015’, provides an overview of the Chronic Obstructive Pulmonary...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6009IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6009IDB
  • View Report: Research and Experts Market Report: Alzheimer

    Alzheimer's Disease - Pipeline Review, H1 2015


    2015-01-30
    Alzheimer's Disease - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Alzheimer's Disease - Pipeline Review, H1 2015’, provides an overview of the Alzheimer's Disease’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6229IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6229IDB
  • View Report: Research and Experts Market Report: Indolent Lymphoma - Pipeline Review, H1 2015

    Indolent Lymphoma - Pipeline Review, H1 2015


    2015-01-30
    Indolent Lymphoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Indolent Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Indolent Lymphoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6162IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6162IDB
  • View Report: Research and Experts Market Report: Squamous Non-Small Cell Lung Cancer - Pipeline Review, H1 2015

    Squamous Non-Small Cell Lung Cancer - Pipeline Review, H1 2015


    2015-01-30
    Squamous Non-Small Cell Lung Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Squamous Non-Small Cell Lung Cancer - Pipeline Review, H1 2015’, provides an overview of the Squamous Non-Small Cell Lung Cancer’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6161IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6161IDB
  • View Report: Research and Experts Market Report: Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H1 2015

    Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H1 2015


    2015-01-30
    Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H1 2015’, provides an overview of the Metastatic Adenocarcinoma of The...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6158IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6158IDB
  • View Report: Research and Experts Market Report: Metastatic Melanoma - Pipeline Review, H1 2015

    Metastatic Melanoma - Pipeline Review, H1 2015


    2015-01-30
    Metastatic Melanoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Melanoma - Pipeline Review, H1 2015’, provides an overview of the Metastatic Melanoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6013IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6013IDB
  • View Report: Research and Experts Market Report: Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2015

    Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2015


    2015-01-30
    Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review,...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6012IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6012IDB
  • View Report: Research and Experts Market Report: Depression - Pipeline Review, H1 2015

    Depression - Pipeline Review, H1 2015


    2015-01-30
    Depression - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Depression - Pipeline Review, H1 2015’, provides an overview of the Depression’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6011IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6011IDB
  • View Report: Research and Experts Market Report: Head And Neck Cancer - Pipeline Review, H1 2015

    Head And Neck Cancer - Pipeline Review, H1 2015


    2015-01-30
    Head And Neck Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Head And Neck Cancer - Pipeline Review, H1 2015’, provides an overview of the Head And Neck Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6010IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6010IDB
  • View Report: Research and Experts Market Report: Peritoneal Cancer - Pipeline Review, H1 2015

    Peritoneal Cancer - Pipeline Review, H1 2015


    2015-01-22
    Peritoneal Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Peritoneal Cancer - Pipeline Review, H1 2015’, provides an overview of the Peritoneal Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6120IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6120IDB
  • View Report: Research and Experts Market Report: Post-Operative Pain - Pipeline Review, H1 2015

    Post-Operative Pain - Pipeline Review, H1 2015


    2015-01-22
    Post-Operative Pain - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Post-Operative Pain - Pipeline Review, H1 2015’, provides an overview of the Post-Operative Pain’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6116IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6116IDB
  • View Report: Research and Experts Market Report: Chronic Plaque Psoriasis - Pipeline Review, H1 2015

    Chronic Plaque Psoriasis - Pipeline Review, H1 2015


    2015-01-22
    Chronic Plaque Psoriasis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Chronic Plaque Psoriasis - Pipeline Review, H1 2015’, provides an overview of the Chronic Plaque Psoriasis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6048IDB has a star rating of 3.5 out of 5
  • Go to More information on Report 05IB-GMDHC6048IDB
  • View Report: Research and Experts Market Report: Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H1 2015

    Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H1 2015


    2015-01-22
    Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Wet (Neovascular / Exudative) Macular Degeneration - Pipeline Review, H1 2015’, provides an overview of the Wet (Neovascular...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6023IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6023IDB
  • View Report: Research and Experts Market Report: Metastatic Pancreatic Cancer - Pipeline Review, H1 2015

    Metastatic Pancreatic Cancer - Pipeline Review, H1 2015


    2015-01-22
    Metastatic Pancreatic Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Pancreatic Cancer - Pipeline Review, H1 2015’, provides an overview of the Metastatic Pancreatic Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6022IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6022IDB
  • View Report: Research and Experts Market Report: Pulmonary Fibrosis - Pipeline Review, H1 2015

    Pulmonary Fibrosis - Pipeline Review, H1 2015


    2015-01-22
    Pulmonary Fibrosis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Pulmonary Fibrosis - Pipeline Review, H1 2015’, provides an overview of the Pulmonary Fibrosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6017IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6017IDB
  • View Report: Research and Experts Market Report: Asthma - Pipeline Review, H1 2015

    Asthma - Pipeline Review, H1 2015


    2015-01-22
    Asthma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Asthma - Pipeline Review, H1 2015’, provides an overview of the Asthma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6007IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6007IDB
  • View Report: Research and Experts Market Report: Breast Cancer - Pipeline Review, H1 2015

    Breast Cancer - Pipeline Review, H1 2015


    2015-01-22
    Breast Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Breast Cancer - Pipeline Review, H1 2015’, provides an overview of the Breast Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6006IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6006IDB
  • View Report: Research and Experts Company Report: Boehringer Ingelheim GmbH - Strategic SWOT Analysis Review

    Boehringer Ingelheim GmbH - Strategic SWOT Analysis Review


    2016-05-03
    Boehringer Ingelheim GmbH (Boehringer) is a pharmaceutical company, which carries out research, development, manufacture and sale of pharmaceuticals. The company offers a wide range of products including prescription medicines, consumer health care produc...
  • Company Report
  • Life Sciences
  • Germany
  • $125.00
  • Report 05IC-GDPH671SA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH671SA
  • View Report: Research and Experts Company Report: Gilead Sciences Inc (GILD) - Financial and Strategic SWOT Analysis Review

    Gilead Sciences Inc (GILD) - Financial and Strategic SWOT Analysis Review


    2016-12-20
    Gilead Sciences Inc (Gilead) is a research-based biopharmaceutical company. It focuses on the discovery, development and commercialization of innovative medicines for diseases with unmet medical need. The company offers products in various therapeutic...
  • Company Report
  • Life Sciences
  • United States
  • $125.00
  • Report 05IC-GDPH5315FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH5315FSA
  • View Report: Research and Experts Company Report: AstraZeneca Plc (AZN) - Financial and Strategic SWOT Analysis Review

    AstraZeneca Plc (AZN) - Financial and Strategic SWOT Analysis Review


    2016-03-22
    AstraZeneca PLC (AstraZeneca) is a global biopharmaceutical company that carries out the design, development, production and commercialization of a wide range of primary care and specialty care medicines. The company’s product portfolio includes...
  • Company Report
  • Life Sciences
  • United Kingdom
  • $125.00
  • Report 05IC-GDPH3904FSA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDPH3904FSA
  • View Report: Research and Experts Company Report: Sanofi (SAN) - Financial and Strategic SWOT Analysis Review

    Sanofi (SAN) - Financial and Strategic SWOT Analysis Review


    2016-11-29
    Sanofi is a healthcare company, which focuses on the research, development, manufacture and marketing of therapeutic solutions. The company offers a wide range of medicines, vaccines and innovative therapeutic solutions. Its product portfolio includes...
  • Company Report
  • Life Sciences
  • France
  • $125.00
  • Report 05IC-GDPH3811FSA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDPH3811FSA
  • View Report: Research and Experts Market Report: Hypocalcemia Global Clinical Trials Review, H2, 2015

    Hypocalcemia Global Clinical Trials Review, H2, 2015


    2015-11-25
    GlobalData's clinical trial report, “Hypocalcemia Global Clinical Trials Review, H2, 2015" provides an overview of Hypocalcemia clinical trials scenario. This report provides top line data relating to the clinical trials on Hypocalcemia....
  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IC-GDHC2992CTIDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IC-GDHC2992CTIDB
  • View Report: Research and Experts Industry Report: Global & USA BioSimilar Market Analysis to 2021; BioBetters, Erythropoietin (EPO), Human Growth Hormone (HGH), Granulocyte Colony-Stimulating...

    Global & USA BioSimilar Market Analysis to 2021; BioBetters, Erythropoietin (EPO), Human Growth Hormone (HGH), Granulocyte Colony-Stimulating Factor (G-CSF), Anti-Tumor Necrosis Factor (Anti-TNF), Monoclonal Antibodies (MAbs), Insulins, Interferons, Produ


    2015-08-01
    Biosimilars are highly-similar versions of biological drugs that are indicated for cancer, kidney disorders and a wide range of autoimmune diseases. Originator biologics are the most expensive drugs in the pharmaceutical industry and many of them cost...
  • Industry Report
  • Biopharmaceuticals
  • Global
  • $3,400.00
  • Report 01B7-2015BM has a star rating of 4.5 out of 5
  • Go to More information on Report 01B7-2015BM
  • View Report: Research and Experts Industry Report: Veterinary Vaccines

    Veterinary Vaccines


    2015-09-01
    Veterinary Vaccines Market research report covers the Types of Veterinary Vaccines and the different Species for which Vaccines are present in the market. The Types of Veterinary Vaccines covered include Live Attenuated, Inactivated, Recombinant and Other...
  • Industry Report
  • Biotechnology
  • Global
  • $5,400.00
  • Report 05HF-RITMIR021 has a star rating of 4.7 out of 5
  • Go to More information on Report 05HF-RITMIR021
  • Industries and Sectors

    • Pharmaceuticals (148)
    • Oncology (57)
    • Infectious Disease... (3)
    • Immunology (6)
    • Healthcare (7)
    • Central Nervous... (10)
    • Life Sciences (88)
    • Cardiovascular (1)
    • Biotechnology (7)
    • Metabolic Disorders... (5)
    • Hematological Disorders... (1)
    • Respiratory (3)
    • Medical Devices (5)
    • Iron and steel Construction... (10)
    • Cosmetics (1)
    • Biopharmaceuticals... (1)

    Geographic Regions

    • Global (330)
    • United States (4)
    • Europe (3)
    • Germany (8)
    • Netherlands (2)
    • Italy (1)
    • United Kingdom (2)
    • France (2)
    • Ireland (1)

    Report Types

    • Market Report (330)
    • Company Report (10)
    • Industry Report (12)
    • Project Profile (1)

    Return to Company List

    Page created and rendered - Cache updated [5.25338s]